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ABSTRACT

Jiang, Chunhui Ph.D., Purdue University, December 2014. Cellular and
molecular regulation of skeletal muscle regeneration. Major Professor: Shihuan
Kuang.
Skeletal muscle regeneration provides a powerful model to study the
cellular and molecular mechanism governing stem cell function since the whole
process is mediated by a population of muscle-resident stem cells called satellite
cells. The overall aim of this dissertation is to explore the roles of Notch signaling
and a novel gene (Bex1) in satellite cell function and skeletal muscle
regeneration.
The first part of this thesis is to examine how the Notch signaling pathway
regulates the satellite cell self-renewal in a disease model. The MDX mouse is a
well-established model for Duchenne muscular dystrophy (DMD) and
characterized by progressive muscle degeneration and regeneration. Here, I
showed that the number and activity of satellite cells in MDX mice were reduced
in an age-dependent manner. Given that satellite cells can self-renew to maintain
the homeostasis, I further demonstrated that the self-renewal capacity was
defective in MDX mice. As the Notch signaling pathway has been reported to
regulate satellite cell quiescence, I continued to confirmed that the self-renewal
defect was due to the perturbed Notch in MDX satellite cells. Furthermore, I

xv
attempted to genetically activate the Notch signaling pathway in satellite cells to
improve muscle regeneration in MDX mice. Surprisingly, although the Notch
activation increased the satellite cell number and rescued the self-renewal
defects, it did not contribute to muscle regeneration. Nevertheless, this study
extends our understanding of the Notch signaling pathway in the activity of
satellite cells and in muscle regeneration.
The second part of this dissertation focuses on the roles of Bex1 in muscle
regeneration. Bex1 is a novel gene with unknown functions in skeletal muscles. I
first found that Bex1 was temporarily expressed in myogenic cells with a nuclearcytoplasmic trafficking pattern during embryonic development and postnatal
regeneration. The exclusive expression of Bex1 in differentiated myocytes
suggests that Bex1 may play unknown roles in regulating myogenic
differentiation. Previous studies suggested that Bex1 could regulate neuron cell
cycle withdrawal. Here I demonstrated that Bex1 participated in myogenic
differentiation independent of the cell cycle withdrawal. Instead, I showed that
Bex1 promoted myoblast-myotube fusion in vitro and the regulation was
independent of myogenic differentiation per se. However, Bex1 knockout mice
appeared normal and did not exhibit obvious defects in the skeletal muscle. This
study characterized the novel function of Bex1 in the myogenesis and facilitated
the understanding of myoblast fusion process.
Collectively, the findings about how Notch signaling and Bex1 regulate the
function of satellite cells as well as muscle regeneration derived from this
dissertation will extend our understanding of the cellular and molecular

xvi
mechanism of muscle regeneration. Consequently, this dissertation can shed
light on providing therapeutic avenues for the prevention and treatment of muscle
diseases.
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CHAPTER 1. INTRODUCTION

1.1

Skeletal Muscle Characteristics

Skeletal muscle constitutes around 50% of body mass and is the largest
organ in our bodies (Huard et al., 2002). Under normal conditions, skeletal
muscles have relatively uniform structure, composed of numbers of myofibers.
Bundles of longitudinally aligned muscle fibers wrapped by extracellular matrix
(ECM) are attached to either tendons or bones through myotendinous junctions,
with blood vessels supplying nutrients and oxygen inside. Besides, adult muscle
tissue contains a variety of interstitial and vessel-associated cells that display
little mitotic activity under resting conditions. Different types of muscles have their
unique structure and composition to fulfil their own specialized functions.
The classic functions of skeletal muscle are posture behavior, locomotive
movement, and respiration. It is well established that skeletal muscles can
contract and generate force through the “sliding mechanism” of myosin-rich thick
filament over actin-rich thin filament upon neuronal stimulation (Huxley, 2000).
Due to different requirements of muscle activities, the muscle fibers themselves
are very heterogeneous in terms of structural and functional properties, referred
as muscle fiber phenotype. Generally speaking, each individual skeletal muscle
is a mixture of myofibers, ranging from a fast-contracting but easy-to-fatigue fiber

2
type to a slow-contracting but fatigue-resistant fiber type (Table 1.1). The overall
contractile property of each individual skeletal muscle is dependent on the
proportion of different fiber types. The regulatory mechanism of muscle fiber type
diversity has been under intensive studies in the past few decades. Motor neuron
has been demonstrated to play key roles in the remodeling process of muscle
fiber type distribution (Calabria et al., 2009). The precise mechanism still remains
elusive (Cavanaugh et al., 2012; Windisch et al., 1998). Taken together, the
functional properties of skeletal muscles depend on a complex framework of
muscle fibers, motor neuron, blood vessel and connective tissues.
Moreover, skeletal muscles play paramount roles in regulating the
metabolism through uptaking glucose from the blood (Zurlo et al., 1990). Skeletal
muscle metabolism is under hormonal control. Under fasting and resting
conditions, blood glucose is mainly consumed by the brain and gut. In contrast,
under the stimulus of insulin, skeletal muscles uptake 75% of blood glucose after
a meal. Exercise training is another regulatory factor of skeletal muscle
metabolism. For instance, endurance training increases the mitochondria content
of skeletal muscles and up-regulates the insulin-sensitive glucose transporter,
GLUT4 (Lessard et al., 2007; Ren et al., 1994). Loss of muscle mass under the
circumstances of aging or degenerative myopathy can also lead to metabolic
syndromes (Biolo et al., 2014). Due to the large volume of skeletal muscles, their
metabolism affects the metabolic condition of the whole organism. As such,
skeletal muscle is the primary site of insulin resistance under many metabolic
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diseases conditions, including type 2 diabetes and obesity (DeFronzo and
Tripathy, 2009).
1.2

Skeletal Muscle Development

In vertebrates, skeletal muscles are derived from paraxial mesoderm, which
segregates into somites, including sclerotome and dermomyotome (Christ and
Ordahl, 1995). The sclerotome, the ventral part of the somites, gives rise to the
cartilage and bone while the dermomyotome, the dorsal part of the somites,
contributes to the skeletal muscles of the body and limbs. During the
embryogenesis, the muscle progenitor cells delaminate from dermomyotome and
migrate to the limb bud, where they proliferate, commit to myogenic lineage and
differentiate into skeletal muscle.
A number of transcriptional factors have been found to coordinately
regulate the progression of myogenic lineage. Importantly, the embryonic
progenitors can be characterized by Pax3/Pax7 expression. Then the myogenic
commitment of muscle progenitor cells requires the up-regulation of two basic
helix-loop-helix transcriptional factors, Myf5 and MyoD. These transcriptional
factors belong to the muscle regulatory factor family (MRFs). In the absence of
these two factors, those cells that originally develop to the muscles remain
multipotent and adopt other cell fates, indicating the indispensable roles in
muscle cell specification (Kablar et al., 1998; Rudnicki et al., 1993). In the
presence of Myf5 alone, the initiation of myogenesis is delayed, suggesting that
Myf5 itself can not sufficiently regulate the onset of myogenesis (Kablar et al.,
1997). After the up-regulation of Myf5 and MyoD, cells proceed to the myoblast
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stage. Then the myoblasts undergo extensive proliferation under the control of a
number of regulatory factors, including Myf5 and MyoD. During the proliferation
stage, some myoblasts withdraw from cell cycle and start to express some latestage MRFs, myogenin and MRF4. The expression of myogenin and MRF4
qualifies a cell as a myocyte, referring to a terminally differentiated muscle cell.
Both myogenin and MRF4 play essential roles in determining muscle
differentiation program, as indicated by severe defects of muscle development in
the myogenin and MRF4 knock-out mice. The myogenin knock-out mice die at
the embryo stage with almost total loss of myofiber formation (Hasty et al., 1993;
Nabeshima et al., 1993). The MRF4 knock-out mice exhibit different phenotypes,
depending on which alleles were deleted (Patapoutian et al., 1995; Yoon et al.,
1997; Zhang et al., 1995). Nevertheless, those phenotypes all indicate the role of
MRF4 in the late stage of myogenesis. With the myogenesis proceeding, the
myocytes fuse to each other to form primary muscle fibers initially. Under the
formation of innervations, another wave of myoblast fusion gives rise to the
secondary muscle fibers. Subsequently, the muscle mass grows extensively
during the fetal period and postnatally. During this muscle development process,
it is noteworthy that some myoblast did not differentiate to myocyte but withdraw
from cell cycle and back to quiescence. Those cells are located between basal
laminin and muscle fiber membrane, defined as satellite cells. They are regarded
as the adult muscle progenitor cells which can initiate the postnatal myogenesis
(Anderson, 2006; Cheung and Rando, 2013; Kuang and Rudnicki, 2008; Wagers
and Conboy, 2005).
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1.3

Skeletal Muscle Regeneration

Under normal conditions, skeletal muscles are relatively stable with little
turnover of myonuclei, no more than 1-2 percent per week (Schmalbruch and
Lewis, 2000). However, skeletal muscles are very susceptible to injuries. In
sports, muscle injuries are very common, covering 10-55 percent of all sustained
injuries (Beiner and Jokl, 2001; Best and Hunter, 2000; Garrett, 1996; Huard et
al., 2002). Skeletal muscle injuries can result from a variety of reasons, including
contusion, strain, laceration, or a mixture of these reasons. As a matter of fact,
more than 90 percent of muscle injuries are contusions and strains, which mostly
lead to physical trauma without significant muscle loss (Beiner and Jokl, 2001;
Counsel and Breidahl, 2010). Under these situations, skeletal muscles have a
robust capacity to initiate a highly orchestrated regeneration process involving
various cellular responses to prevent further muscle loss.
In spite of the types or severity of muscle injuries, muscle regeneration
follows a stereotype, which can be generally divided into two phases listed as
follows.
i.

The decomposition and inflammatory phase characterized by the necrosis
of muscle fibers and the activation of inflammatory responses.

ii.

The repair and remodeling phase characterized by the phagocytosis of
necrotic muscle fibers, generation of new muscle fibers by myogenic cells
and formation of a tissue scar.
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1.3.1 The Degeneration Phase
Muscle degeneration starts with the necrosis of damaged muscle fibers.
Following muscle injury, the sarcolemma of muscle fibers are disrupted, leading
to the increased muscle fiber permeability. Consequently, the intracellular
proteins of muscle fibers can be released to the extracellular environment, such
as creatine kinase. The expression of creatine kinase is usually restricted to the
cytosol of muscle fibers. Therefore its elevated level in serum can indicate the
occurrence of lesions of the muscle cell membrane (Coulton et al., 1988; Percy
et al., 1979). Similarly, it was recently demonstrated that the serum levels of
several muscle specific RNAs (myoMIRs), including mir1, mir206 and mir133,
can also serve as biomarkers for muscle degeneration (Mizuno et al., 2011;
Zaharieva et al., 2013). On the other hand, some extracellular substances may
diffuse into the muscle fibers. Based on this assumption, various dyes have been
developed to faithfully mark the degenerated fibers since they can be easily
absorbed by damaged muscle fibers (Hamer et al., 2002; Palacio et al., 2002).
The most significant event due to the increased permeability is the influx
of calcium or calcium release from sarcoplasmic reticulum. The loss of calcium
homeostasis leads to activation of calcium-dependent proteolysis and promotes
the rapid disintegration of myofibrils. For instance, calpains are calciumactivated proteases and play key roles in the decomposition of myofibril and
cytoskeletal proteins (Belcastro et al., 1998).
During the early phase of muscle degeneration, the degradation of muscle
fibers is accompanied with the infiltration of inflammatory cells. Previous studies
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have demonstrated that the injured muscle fibers can release signals to activate
the inflammatory cells residing in the muscles. Afterwards, those local
inflammatory cells can continue to recruit leukocyte cells to the damaged sites
via the chemotactic machinery. Specifically, neutrophils and macrophages are
two major inflammatory cells in response to muscle injury (Arnold et al., 2007;
Pizza et al., 2005).
Upon muscle damage, neutrophils migrate rapidly to the injury site within 6
hours, which evokes the local inflammation response. It is well established that
neutrophils have a robust capacity to produce reactive oxygen species (ROS).
Therefore as the neutrophils function, the dramatic increase of ROS levels speed
up the disruption of muscle fiber structure (Fielding et al., 1993; Orimo et al.,
1991). Subsequently, neutrophils are replaced by macrophages, the most
predominant inflammatory cells invading injury sites. Basically, two distinct
macrophages function in the muscle regeneration. At first, M1 macrophages
characterized by the surface marker CD68+/CD163-, reach the concentration
peak within 24 hours post onset of muscle injury and decrease rapidly afterwards.
These M1 macrophages can secrete pro-inflammatory cytokines to promote
inflammation and phagocytize cellular debris. Then M2 macrophage,
characterized by the surface maker CD68-/CD163+, secretes anti-inflammatory
cytokines, which sustain until the termination of the inflammation (Cantini et al.,
2002; Lescaudron et al., 1999; Sonnet et al., 2006).
It is worth mentioning that both neutrophils and macrophages have
significant roles in regulating the behavior of satellite cells. In detail, neutrophils
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can activate satellite cells to the injury sites while macrophages can regulate the
proliferation and differentiation of satellite cells (Merly et al., 1999; St Pierre
Schneider et al., 2002), both of which prepare muscle tissue to proceed to the
next stage, muscle repair phase.
1.3.2 The Repair Phase
Skeletal muscle regeneration has drawn intense attention for quite a long
time in that muscle regeneration recapitulates embryonic myogenesis to some
extent, which provides a powerful model to study muscle development. Longstanding histological characteristics are still being utilized to distinguish
regenerating muscle fibers, such as the relatively smaller caliber and centrally
located nuclei (Hall-Craggs and Seyan, 1975).
The muscle regeneration is a complex but highly synchronized process.
The hallmark of this stage is represented by the extensive cell proliferation
(Grounds et al., 2002; Hawke and Garry, 2001). During the regeneration process,
various types of cells infiltrate in the injury sites, including satellite cells,
inflammatory cells, blood vessel cells, neuron cells and so forth. Satellite cells
migrate to the injury sites and differentiate to myoblasts. These myoblasts can
undergo extensive proliferation to reach the sufficient cell number, which is
extremely important for muscle regeneration, as indicated by the reduction of
regeneration capacity after treated with proliferation inhibitors or irradiation
(Quinlan et al., 1995; Wakeford et al., 1991; Weller et al., 1991). Those large
quantities of myoblasts can either fuse to the existing muscle fibers for repair or
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fuse with each other to form new muscle fibers (Darr and Schultz, 1987; Snow,
1978).
Of note, the myoblasts are not the only source of progenitor cells which are
responsible for muscle regeneration. This raises intense interest and controversy
concerning whether and how other muscle-derived stem cells and circulating
progenitor cells can contribute to the muscle regeneration. To date, there are
several types of cells isolated from skeletal muscles, which have been
demonstrated to give rise to myogenic lineage cells, including bone marrow stem
cells, muscle side population cells, PW1+ interstitial cells, mesoangioblasts,
pericytes, and post-natal muscle derived stem cells, and CD133+ cells and so
forth (Lee et al., 2000; Peault et al., 2007; Peng and Huard, 2004). Currently, it
remains unknown how significantly these cells contribute to myogenic
differentiation.
Among those different cell populations, post-natal muscle derived stem
cells displays several advantages over other cell populations in cell
transplantation treatment, including remarkable multipotency and long-term
survival rate (Cao et al., 2003; Deasy et al., 2005; Lee et al., 2000). In addition,
the origin of these post-natal muscle derived stem cells has been a topic of great
interest. Emerging evidences show that those cells are from vascular
endothelium (Tavian et al., 2005), suggesting that augmenting vascular supply to
the wound area may be conducive to muscle regeneration.
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1.4

Satellite Cells

Satellite cells were first observed around half a century ago (Mauro, 1961).
These cells have been regarded as muscle stem cells in that satellite cells have
been demonstrated to have the capability to replenish themselves and give rise
to myogenic progeny (Bischoff, 1975; Collins et al., 2005; Konigsberg et al., 1975;
Kuang et al., 2007; Lipton and Schultz, 1979; Montarras et al., 2005; Moss and
Leblond, 1971; Sherwood et al., 2004). The identification of satellite cells raised
them as the top candidate for post-natal muscle growth and regeneration. Indeed,
they do play indispensable roles in muscle regeneration under a complex
regulatory network, which has stimulated researchers to develop cell-based
strategies to treat degenerative muscle diseases, such as Duchnne Muscular
Dystrophy. However, the efficiency of these strategies is limited due to the low
survival rate and migration capacity of the transplanted cells. Therefore it is
imperative to make a more comprehensive understanding about satellite cell
characteristics in order to manipulate quiescence, proliferation and differentiation
of satellite cells.
1.4.1 Identification of Satellite Cells
Satellite cells can be identified based on a unique location with the
perspective of anatomy. They are located between the basal lamina and the
muscle fiber membrane along the whole fiber. Under the electron microscope,
satellite cells with the “wedge” appearances exhibit condensed interphase
chromatin, which is consistent with the notion that most satellite cells stay in the
quiescent state and are transcriptionally inactive in the resting muscles (Mauro,
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1961; Schultz et al., 1978). In addition, satellite cells can be identified in single
fibers isolated from skeletal muscles through immuno-fluorescence imaging,
which is dependent on specific biomarkers. In adult skeletal muscle, nearly every
satellite cell expresses the paired box 7 (Pax7), which has been well-accepted as
the canonical biomarker for satellite cells (Seale et al., 2000). Besides, a number
of transcriptional factors have been utilized in identification of satellite cells, such
as Pax3 and Myf5 (Buckingham et al., 2003; Cornelison and Wold, 1997). Also,
some membrane proteins have been implicated in the identification of satellite
cells, such as cell surface attachment receptor alpha7-intergin (Burkin and
Kaufman, 1999; Gnocchi et al., 2009) and cell adhesion protein M-cadherin
(Irintchev et al., 1994). It is noteworthy that some of these aforementioned
markers can also be expressed in other types of cells. Therefore, it is necessary
to identify satellite cells with combined fluorescence labeling.
1.4.2 Niche Regulation of Satellite Cells
In adult skeletal muscles, satellite cells are a major source for muscle
regeneration. In resting conditions, satellite cells are mitotically inactive. Upon
injury, satellite cells undergo a process of cytoplasmic volume expansion and
heterochromatin reduction to become mitotically active. After satellite cells enter
the cell cycle, they start to up-regulate the expression level of the basic helixloop-helix transcriptional factors Myf5 and MyoD then progress to the highly
proliferative myoblasts. During the proliferation, some cells withdraw from the cell
cycle and start to express myogenin, subsequently differentiating to the new
muscle fibers while the others lose their myogenic signature by down regulating
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the expression level of MyoD and return to the quiescent state to replenish
satellite cell pools (Bentzinger et al., 2012). During the whole process of muscle
regeneration, the behaviors of satellite cells, including self-renewal, proliferation
as well as differentiation, are under a precisely coordinated regulation by the
surrounding cells which constitute the satellite cell niche.
In adult skeletal muscles, the total number of satellite cells remains
relatively constant even with multiple rounds of muscle injury and repair. This
homeostasis is largely attributable to the self-renewal capacity (Collins et al.,
2005). The regulation of self-renewal is predominantly dependent on the extrinsic
factor released by the surrounding cells residing in the satellite cell niche. Indeed,
the cellular constituents of satellite cell niche are under a dynamic state. In
particular, the components of quiescent satellite cells niche are significantly
different from those of activated satellite cells niche. When satellite cells are
quiescent, the satellite cell niche contains relatively less cell types, such as
muscle fibers and vessel-associated cells.
Besides, this microenvironment remains static and exerts effects on
maintenance of satellite cell quiescence through a variety of signaling pathways.
Previous studies have corroborated that Notch signaling pathway plays key roles
in the maintenance of satellite cell quiescence, wherein the genetic deletion of
Rbpj, a main effecter of the Notch signaling pathway, activates satellite cells
significantly (Bjornson et al., 2012; Mourikis et al., 2012). Considering the relative
few cell types in the quiescent satellite cell niche, the Notch regulation may be
derived from the muscle fibers within the satellite cell niche.
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During cell proliferation, apart from a small proportion of satellite cells
return to the quiescence, the majority of satellite cells remain active and further
become more differentiated myogenic cells. This process is also under the
regulation of circumambient cells in the niche. However, comparing to the
quiescent niche, the niche of activated satellite cells becomes much more
complicated with a spectrum of infiltrating cells.
First of all, immune cells play critical roles in regulating the behavior of
activated satellite cells, also called myoblasts. In response to muscle injury,
varieties of immune cells are quickly recruited to the wound sites and infiltrate to
the niche. In particular, the predominant immune cells invading the injury sites
are macrophages, basically with two subtypes, M1 and M2. M1 macrophages
can promote myoblast proliferation while M2 can induce myoblast differentiation
(Deng et al., 2012; Ruffell et al., 2009). This is supported by the observation that
M1 macrophages accumulate close to the proliferating myoblast while M2
macrophages are proximate to the differentiating myogenic cells (Saclier et al.,
2013).
Secondly, fibrogenic cells are also major contributors involved in the niche
regulation. It is well agreed that the extracellular matrix (ECM) play key roles in
regulating satellite cell behaviors. During muscle regeneration, ECM in the niche
is largely and dynamically reorganized (Goetsch et al., 2003). In this process,
fibrogenic cells including fibroblast and FAPs (fibro/adipogenic progenitors) can
contribute to the deposition of several ECM components, such as different
collagen isoforms, which participate in the niche regulation. It is noteworthy that
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the FAPs and the myogenic cells can interplay with each other. FAPs can
secrete IL6 to induce myogenic differentiation while the formation of myotube
inhibits the differentiation of FAPs to adipocytes (Joe et al., 2010; Uezumi et al.,
2010). In addition, the endothelial and periendothelial cells as well as the muscle
lineage cells all play important roles in the niche regulation of activated myoblast
(Abou-Khalil et al., 2010).
Due to the complicated constituents of the activated niche, the
mechanisms that integrate different cell types are highly complex and further
studies will unravel promising concepts in basic stem cell biology and also
provide therapeutic avenues for muscular diseases.
1.4.3 Heterogeneity of Satellite Cells
Satellite cells were first considered as a homologous population of cells,
which are committed muscle progenitor cells. As technology advances, emerging
evidence has demonstrated that satellite cells are a heterogeneous group with
respective to several characteristics, such as gene expression profiles, myogenic
differentiation potential and intrinsic self-renewal capacity.
As for the gene expression profile of satellite cells, it is worth mentioning
that the satellite cells do not always express those aforementioned satellite cell
markers. For instance, examination of the aforementioned markers, CD34 and
M-cadherin, revealed that a group of satellite cells are lack of those markers
(Beauchamp et al., 2000). Recently, several novel biomarkers for satellite cells
have been discovered with different expression patterns. The nuclear envelope
proteins lamin A/C and emerin were universally found to be expressed in
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quiescent and activated satellite cells whereas Jagged-1, a Notch ligand, was
preferably expressed in activated satellite cells (Gnocchi et al., 2009). Therefore,
the molecular signatures of satellite cells vary greatly. The combination of those
biomarkers may have great implication in delineating the subpopulation of
satellite cells and further interpreting the biological function of different
subpopulations. However, the biological significance of this heterogeneity still
needs to be clarified.
Satellite cells are very heterogeneous in their propensity of myogenic
differentiation. It was observed that satellite cells from different types of muscles,
including tibialis anterior (TA), extensor digitorum longus (EDL) and soleus, can
contribute to the muscle regeneration differently after transplantation into
MDX/nude mice (Collins et al., 2005). This result implies that the different
sources of satellite cells are distinct inherently in the potential of myogenic
proliferation/differentiation. It can be supported by another observation of varied
levels of Myf5 in satellite cells, with Myf5 heterozygous cells more committed to
myogenic differentiation compare to wild type control (Gayraud-Morel et al.,
2012). This heterogeneity of satellite cells in myogenic differentiation may have a
great advantage to effectively balance between satellite cells pool maintaining
and myogenic differentiation requirement.
Another evidence of satellite cells heterogeneity comes from their intrinsic
self-renewal activity. It has been corroborated that satellite cells are
heterogeneous based on the expression level of Myf5, one of the earliest
transcriptional factors for myogenic commitment (Kuang et al., 2007). In detail,
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Myf5- satellite cells defined a 10% subpopulation while Myf5+ satellite cells
represent the other 90%. It has been demonstrated that the Myf5- satellite cells
can give rise to Myf5+ cells, indicating a hierarchical relationship between those
two subpopulations. Cell transplantation experiments demonstrated that Myf5satellite cells can not only undergo myogenic differentiation but also replenish
satellite cell pools while Myf5+ satellite cells cannot self-renew but readily
differentiate for muscle regeneration, which suggests that the self-renewal
capacity resides in the Myf5- satellite cell subpopulation rather than Myf5+ cells.
Altogether, these observations revealed the heterogeneity of self-renewal
capacity residing in satellite cells. In this way, only a paucity of satellite cells can
be regarded as true stem cells.
In summary, a variety of studies have substantiated that satellite cells are
a very heterogeneous population. However, the biological significance of this
heterogeneity remains poorly understood. Moreover, the intrinsic difference
between these heterogeneous subpopulation at the molecular and functional
levels needs to further clarified, which will facilitate in elucidating the mechanisms
defining the different subpopulations as well as manipulating satellite cell
behaviors in muscle regeneration.
1.4.4 Mechanisms of Satellite Cell Self-renewal
Due to the critical roles of self-renewal, the mechanism governing selfrenewal has drawn intense attention in the field. In general, it was proposed that
satellite cells can replenish themselves either through an asymmetrical division
generating one quiescent daughter cell and the other differentiating daughter cell
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or through a stochastic process wherein the progeny cells are the same at first
but they take different cell fates afterwards.
Emerging studies have demonstrated that satellite cells undergo selfrenewal through asymmetrical cell division. One of the evidence is based on the
distribution of Numb, one cell fate determinant, in the daughter cells after cell
division. It was observed that Numb is asymmetrically distributed in some but not
all satellite cells (Conboy and Rando, 2002). In line with this observation, by
BrdU labeled DNA strand segregation experiment, it was discovered that all “old”
template DNA strands are co-segregated to the more stem-like daughter cells
expressing the stem cell marker Sca1. Concomitantly, all “younger” template
DNA strands are inherited by more differentiating daughter cells expressing the
differentiation marker Desmin (Conboy et al., 2007). Based on the “immortal DNA
strand” theory, the retention of old DNA strand can protect stem cells from
accumulating mutations during DNA replication. Furthermore, it has been directly
observed that the non-committed Pax7+Myf5- satellite cell can divide
asymmetrically into two daughter cells with different orientation in the satellite cell
niche, wherein one non-committed Pax7+Myf5- daughter cell is exposed to the
basal lamina and the other committed Pax7+Myf5+ daughter cell is exposed to
the host myofiber (Kuang et al., 2007).
In summary, through asymmetrical cell division, satellite cells can
continuously replenish satellite cell pools in the course of muscle regeneration.
This asymmetrical division pattern has been proposed to be dependent on the
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different signals. But it remains unclear which signals play predominant roles and
how these signals coordinate with each other to determine satellite cell fates.
1.5

Duchenne Muscular Dystrophy

During the contraction of muscle fibers, the fibers have a particular protein
complex structure to buffer against mechanical stress. Genetic mutation of the
elements of the complex can cause muscular dystrophy with different extents in
term of onset age and dysfunctional muscles as well as severity, depending on
how the mutated product affects the mechanosensory signaling network. Due to
the genetic defects, muscular dystrophy is characterized by the progressive
muscle weakness and degeneration. However, muscles have multifaceted repair
system for regeneration. Upon injury, muscles can readily response to the stimuli
and initiate a series of orchestrated events to fulfill the regeneration process.
Thus, the pathophysiological hallmark of muscle dystrophy is repetitive muscle
necrosis and regeneration. With the diseases advances, muscle degeneration
gradually overtakes the regenerative capacity. Consequently, the muscle fibers
are replaced by the fibrotic and adipose tissue, which leave muscle increasingly
weak and eventually nonfunctional.
1.5.1 Characteristics of Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy (DMD) is the most severe muscular
dystrophy, characterized by widespread muscle wasting, leading to loss of
mobility, cardiovascular and respiratory failure, and finally death. DMD is an Xlinked recessive muscular disorder with one of the highest mutation rates,
affecting1 in 3500 male births (Blake et al., 2002). DMD patients are usually

19
bound to wheelchairs by 12 years age and died of respiratory failure in their early
twenties. DMD is caused by mutations in the Dystrophin gene which is regarded
as the largest in the human genome, containing 2.6 million bp DNA and 79 exons.
It was estimated that around 60% mutations are the major frame-shift errors in
the genome due to insertions and deletions while around 40% are due to point
mutations and minor genome rearrangements (Hoffman and Dressman, 2001).
During muscle contraction, dystrophin can provide a structural link
between the cytoskeleton and the extracullular matrix by binding to the actin with
the amino-terminus as well as to the sarcolemma with the carboxyl-terminus
through Dystrophin Associated Protein Complex (DAPC) (Brenman et al., 1996;
Ibraghimov-Beskrovnaya et al., 1992; Rybakova et al., 2000). To form the
complex, dytrophin first binds to the transmembrane β-dystroglycan together with
α-dystroglycan, which constitutes the dystroglycan subcomplex. Also, four
isoforms of sarcoglycans can complex with sarcospan to form the sarcoglycan
subcomplex. Additionally, two cytoplasmic components, dystrobrevins and
syntrophins, can be anchored to the carboxyl terminus of dystrophin. Of note,
syntrophins can interact with nitric oxide synthase (NOS) (Adams et al., 2001;
Ibraghimov-Beskrovnaya et al., 1992), which can regulate oxidative stress
through NO production, and the recruitment of NOS to the sarcolemma is largely
dependent on dystrophin (Brenman et al., 1995; Chang et al., 1996). In summary,
DAPC has both structural/mechanical and signaling roles to maintain the integrity
of sarcolemma.
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1.5.2 Pathophysiology of Duchenne Muscular Dystrophy
In DMD, the absence of dystrophin renders the muscle membrane fragile
to normal contraction. The disruption of membrane initiates a series of
degeneration events as well as cellular protective responses. Currently, several
pathophysiological perspectives have been investigated, including membrane
fragility, impaired calcium homeostasis, and free radical damages. A
comprehensive understanding of the pathophysiology underlying the deficits due
to the absence of dystrophin will facilitate in developing new approaches for the
treatment of Duchenne muscular dystrophy.
1.5.2.1 Membrane Fragility
Membrane fragility in DMD patients has been corroborated by multiple
lines of evidence. It was demonstrated that myofibers in DMD patients
accumulate various non-muscle proteins, indicative of membrane permeability.
Consistent with this observation, several muscle-specific proteins and
microRNAs, have been detected in the serum of DMD patients (Mizuno et al.,
2011; Percy et al., 1979). These results can be supported by electron microscopy
observation of membrane lesion in the DMD muscles (Mokri and Engel, 1975).
To make matters worse, the compromised integrity of the sarcolemma
deteriorates under sustained exercise, especially eccentric contraction.
Sustained exercises can cause lesion of myofiber membrane, which could be
detected by the incorporation of Evans Blue, a dye developed for detection of
muscle membrane permeability (Hamer et al., 2002). It was found that dystrophic
muscles had tendency to incorporate more Evans Blue compared to WT controls
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under sustained exercise (Straub et al., 1997). Notably, eccentric contraction
represents the muscle contraction to the maximal length, which exerts significant
mechanical stress on the sarcolemma. With the eccentric contraction, the ability
of maintaining sarcolemma integrity in DMD patients is drastically reduced
(Petrof et al., 1993). Therefore, the membrane fragility under mechanical stress
contributes to the pathology of DMD, which suggests that physical therapy may
be mandatory while excessive activity can be harmful to stabilize muscle
condition in DMD patients.
1.5.2.2 Impaired Calcium Homeostasis
Calcium homeostasis is essential for a variety of muscle functions. Loss of
calcium balance leads to dysfunctional muscles in various muscle diseases,
including Duchenne muscular dystrophy. Indeed, impaired calcium homeostasis
could be a signature event in the onset of muscular dystrophy as calcium influx
was sufficient to induce dystrophic phenotype (Millay et al., 2009).
The approaches by which extracellular calcium enters the muscle cells
have not been fully clarified. It was speculated that extracellular calcium enters
muscle fibers simply through disrupted membrane. However, multiple lines of
evidence demonstrated that extracellular calcium entered the dystrophic muscles
by specific channels (Alderton and Steinhardt, 2000; Franco and Lansman, 1990;
Matsumura et al., 2011; Yeung et al., 2005). These channels have been detected
with altered expression levels in dystrophic muscles. More relevantly, overexpression of these channels could result in the cardiomyopathy, which further
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suggests that these channels have pathological implication in muscular
dystrophy (Iwata et al., 2003; Millay et al., 2009).
The calcium homeostasis was not promptly destroyed upon membrane
disruption. Indeed, given that muscle fibers have strong capability to balance the
calcium concentration, the calcium homeostasis can be maintained within a short
period. With the influx advances, high amount of extracellular calcium inevitably
subverts the muscle’s capacity of maintaining calcium concentration and
subsequently activates a number of calcium-dependent proteases. In particular,
calpains can be activated by the calcium influx and play paramount roles in the
degradation of muscle membrane protein, which further induces muscle necrosis.
The pathophysiology of calcium influx has shed light on new strategy to improve
muscle dystrophic phenotype. As such, some progress has been made to
improve dystrophic phenotype by means of introducing the blockers of calcium
channels and inhibitors of calcium-dependent proteases (Bonuccelli et al., 2003;
Iwata et al., 2009; Yeung et al., 2005). Further attempts should be focused on
investigating the detailed mechanism how calcium influx occurs during the onset
of dystrophic phenotype.
1.5.2.3 Free Radical Damage
Free radical damage, also referred as oxidative stress, has been
extensively investigated in various pathological conditions, including muscle
wasting and muscular dystrophies (Arthur et al., 2008; Rando, 2002). It has been
defined as the pathological condition wherein the endogenous antioxidants have
been overweighed by the reactive oxidant species (ROS). It has been
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determined that dystrophin-deficient myotubes are susceptible to oxidative
damages (Rando et al., 1998), suggesting that oxidative stress may be involved
in the pathophysiology of muscle dystrophy.
One of the most characterized molecules associated with oxidative stress
is Nitric Oxide (NO), which can be generated by the neuronal nitric oxide
synthase (nNOS). It has been shown that nNOS directly binds to the syntrophins,
one component of DAPC, indicating that the collapse of DAPC in dystrophic
muscles might lead to disturbance of NO generation. Indeed, the dissociation of
DAPC results in the translocation of nNOS from plasma membrane to cytoplasm
as well as a concomitant reduction of NO production. Conversely, ectopic
expression of nNOS could dramatically rescue the dystrophic phenotype
(Wehling et al., 2001). Paradoxically, NO plays dual roles in the process of
oxidative stress, indicated by previous study showing that NO can function not
only as a free radical reacting with superoxide but also as an antioxidant to
relieve oxidative stress (Touboul et al., 2005). Therefore, the pathological
implication of NO in muscular dystrophy is complicated and it needs further
attempts for complete understanding and therapeutic manipulation. Nevertheless,
introducing antioxidants to the dystrophic mice dramatically reduced the muscle
degeneration (Buetler et al., 2002; Nakae et al., 2012). In summary, the free
radical mediated muscle damage participates in the pathophysiology of muscle
dystrophy, although the detailed mechanism needs further investigation.
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1.5.3 Therapies of Duchenne Muscular Dystrophy
To date, there are no effective therapies for DMD, but a number of
therapeutic strategies have been shown to delay or ameliorate the symptoms.
Many of these therapies are merely effective to some extent in that they may aim
at one aspect of the DMD pathogenesis. In particular, restoring the expression of
dystrophin has been a promising trial for DMD therapy. It has been shown that as
low as 30% restoration of dystrophin can prevent muscle weakness (Neri et al.,
2007). However, due to the large amount of muscle mass including cardiac
muscles and skeletal muscles, even 30% restoration has been a great challenge.
Moreover, the restoration should be durable, which exposes another
considerable hurdle to the therapy. Recently, significant progress has been made
in seeking new strategies for DMD therapies, including gene therapies and cell
therapies. Gene therapies can be performed by the traditional approach with
direct protein replacement or the nascent methods involving manipulation of
gene expression through modulation of transcription, post-transcriptional
processing and translation. Cell therapies can be mediated by transplantation of
stem cells bearing a functional Dystrophin gene, including autologous and
allogenic transplantation depending on cell sources. The lessons from these
therapies also shed light on the therapeutic treatment of other genetic disorders.
1.5.3.1 Dystrophin Restoration by Viral Delivery
Direct recovery of absent protein can be executed through viral gene
delivery. In the past few decades, the genome information of virus and the
mechanism of viral infection become transparent gradually, which significantly
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relieves people’s concern in the utilization of this viral therapy. As such, viral
gene therapy has been applied in the treatment of multiple disorders due to its
specific advantages in the efficiency of gene delivery.
Currently, vectors derived from adeno-associated virus (AAV) are the
most promising vehicles for therapeutic gene delivery. It has been documented
that AAV delivery proved effective and durable in some clinical trial
(Vandenberghe and Auricchio, 2012). Still, this strategy faces significant
challenges due to the immune response. Considering the large size of dystrophin,
viral delivery of Dystrophin gene could probably evoke more intense immune
response. Alternatively, several strategies using dystrophin fragment have been
designed to include functional motifs to override the mutant carried in the patient,
such as delivery of a functional fragment containing neuronal nitric oxide
synthase (nNOS) binding sites (Lai et al., 2009).
Another limitation of viral gene therapy is to deliver dystrophin systemically.
Local delivery of the Dystrophin gene under muscle specific promoters has been
successful with no observed adverse effects (Wang et al., 2012). Due to the
complexity of body system, systemic delivery requires further investigation on the
vector design, particularly the promoter design. Also the durability after gene
delivery is also a limiting factor of this therapy. To date, it remains unknown how
long the dystrophin expression can be sustained after one delivery.
Taken together, viral gene delivery has been a promising approach but
requires further studies to overcome immune responses essentially.
1.5.3.2 Dystrophin Restoration by Exon Skipping
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Exon skipping holds promise in the treatment of muscular dystrophy. This
strategy aims to correct the out-of-frame mutation by skipping the splicing of
mutated exons and restoring the downstream frame, which could form a
truncated but partially functional dystrophin protein. Recently, exon skipping has
restored the dystrophin expression to a decent level in some clinical trials.
Technically, different types of RNaseH dependent antisense oligonucleotides
(AON) were designed to hybridize the sequences in or around the target exons to
block the binding of splicing regulatory proteins and consequently skip the
splicing of the mutated exon (Cirak et al., 2011; van Deutekom et al., 2007). To
further optimize this strategy and enhance the efficiency of treatment, several
bottleneck issues need to be emphasized.
First of all, the strategy is highly personalized and mutation specific, which
means some mutated exons are easier to skip while the others are not. This is
supported by the fact that some DMD patients can respond to the strategy
effectively while some others have no responses (Mitrpant et al., 2009). One
possible solution is to design multiple-exon skipping OANs, which has been
confirmed to be feasible in principle (Aoki et al., 2012). Secondly, although AONs
have been well tolerated with no safety issues at present (Kinali et al., 2009; van
Deutekom et al., 2007), the long-term safety issues remain to be clarified, which
is important especially for this life-long treatment. Next, the efficiency of AONs is
restricted due to the poor cellular uptake, leading to variable levels of dystrophin
restoration in skeletal and cardiac muscles.
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Overall, although there are still several major obstacles in clinical trials,
exon skipping has displayed promising therapeutic value in the DMD treatment.
1.5.3.3 Utrophin Compensation
Utrophin has been regarded as an autosomal homologue of dystrophin,
and they share similar sequences and structures (Davies and Nowak, 2006).
Moreover, utrophin can interact with members of DAPC and has the same
function as dystrophin, which provides a bridge between cytoskeleton and
extracellular matrix.
The major difference between utrophin and dystrophin is the expression
pattern. In detail, dystrophin can be expressed along the whole muscle fibers
while utrophin is restricted to the neuromuscular and myotendinous junctions. It
has been observed that utrophin is increased and expanded beyond the
neuromuscular and myotendinous junctions in dystrophic muscles, indicative a
compensatory effect of dystrophin loss (Kleopa et al., 2006). This is also
supported by the phenotype of dystrophin/utrophin double knockout mice, which
have much worse phenotypes compared to dystrophin-deficient MDX mice
(Deconinck et al., 1997).Furthermore, multiple studies have provided compelling
evidence that the dystrophic phenotype can be ameliorated by increasing
utrophin in muscles through a variety of approaches, including direct upregulation of utrophin transcription, direct delivery of utrophin protein, and
stabilization of endogeneous utrophin RNA or protein (Chakkalakal et al., 2008;
Moorwood et al., 2013; Sonnemann et al., 2009; Tinsley et al., 2011).
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In addition, utrophin has been observed to accumulate more in the slow
oxidative muscle fibers comparing to the fast glycolytic muscle fibers. This has
great implication since the slow oxidative muscle fibers can be more resistant to
the dystrophic pathology in DMD patients (Webster et al., 1988). Therefore,
promotion of slow oxidative myogenic program may be beneficial to the treatment
of DMD. Activation of the calcineurin-NFAT (nuclear factor of activated T cells) or
PGC1-α (peroxisome proliferator activated receptor γ coactivator 1 α) has been
determined to promote slow oxidative program and increase the expression level
of utrophin, which significantly improved dystrophic phenotype (Chakkalakal et al.,
2004; Ljubicic et al., 2014; Selsby et al., 2012).
Compared to other gene therapies, utrophin compensation holds more
significant therapeutic promise in that this strategy of increasing utrophin is
effective irrespective of the dystrophin mutations and it can circumvent the hurdle
of immune response in the dystrophin-based therapies.
1.5.3.4 Stem Cell Mediated Therapies
Cell therapies have gained intense interest for muscular dystrophy
treatment and were carried out in the clinical trials earlier in the 1990s (Gussoni
et al., 1999; Mendell et al., 1995).The strategy of cell therapies is to transplant
cells bearing the functional Dystrophin gene to the dystrophic muscles.
Theoretically, those transplanted cells could not only migrate to the injury sites
for regeneration but also inhabit in the satellite cell niche to self-renew for future
use. To date, multiple types of cells have been utilized for dystrophy therapies.
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The first attempt of DMD cell therapy was to transplant myoblasts to the
dystrophic muscles thanks to the ease of myoblast culture. This was first
examined in MDX mice, and the results showed that transplanted myoblasts
fused to MDX myofibers and relayed the expression of dystrophin in the
dystrophic muscles (Partridge et al., 1989). However, myoblast transplantation in
clinical trials failed to provide decent increase of dystrophin in DMD patients
(Miller et al., 1997), which may be due to the low survival rate and inability to
migrate. To improve this, multiple injections of large quantities of myoblasts were
performed, leading to around 10% dystrophin production in the injury sites (Skuk
et al., 2007). Still, the low efficiency of transplantation elicits researchers to seek
other choices for cell therapies.
Compared with myoblasts, satellite cells point to a promising candidate for
cell therapy of muscular dystrophy in that they could enter the satellite cell niche
to self-renew and provide a long-time treatment. Satellite cells could be purified
based on the surface markers and transplanted to MDX mice. After
transplantation, those satellite cells contributed to 97% fibers and significantly
improved muscle performance (Cerletti et al., 2008), yet several hurdles of
satellite cell mediated therapy still need to be overcome. One of them is the
inability to migrate over long distances, which restricted satellite cell therapy to
local injection. Another challenge may come from the lower myogenic potential of
satellite cells, which consequently reduced the efficiency of satellite cell therapy.
A promising direction is to transplant cells with the matrix, such as myofibers,
which have opened new fields in tissue engineering.
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In addition to myoblasts and satellite cells, several other types of cells also
have been studied for cell therapies of muscular dystrophy, such as bone marrow
derived stem cells (Ferrari et al., 1998) and mesoangioblasts (Sampaolesi et al.,
2006). Compared to myoblasts and satellite cells, these non-myogenic cells have
advantages in the systematic delivery as they could be delivered to muscles
through circulatory system, yet the main challenge how to increase the myogenic
potential remains to be explored.
1.5.4 Animal Models of Duchenne Muscular Dystrophy
1.5.4.1 Mouse Models
To date, several animal models have been developed to study the
fundamental principles and test the therapeutic approaches for DMD. The MDX
mouse is the most widely used homologous animal model. The MDX mouse
features a premature stop codon mutation in exon 23 of the Dystrophin gene,
leading to little or no dystrophin protein production . The MDX mouse was born
normal until the third postnatal week when the widespread muscle necrosis was
initiated due to the absence of dystrophin. The muscle degeneration is followed
by extensive muscle regeneration, indicated by centrally nucleated muscle fibers
persisting through life. The MDX mouse has been a valuable tool for DMD study
due to the genetic background and histological features.
However, there have been also quantities of debates on the value of the
MDX mouse as a DMD model. The reason why so many debates arise is that the
pathology of MDX is far more benign than that of DMD patients. In detail, the
lifespan of MDX mouse is similar compared to the wild type mouse. The
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cardiomyopathy and fibrosis, typical characteristics of severe dystrophic
phenotype, do not occur until MDX mouse undergoes aging. This drawback has
significantly limited the utilization of MDX mouse and impeded the translation to
the human clinical trial of data gathered from MDX. To date, great efforts have
been dedicated to improve the application of the MDX mouse by virtue of
breeding it to the mouse with other genetic background.
The first attempting of breeding MDX with other genetic mouse was
performed on the nude mouse when scientists aimed to reduce the immune
responses during myogenic transplantation. Although this breeding did decrease
the immune rejection as expected, the nude background had predominant effects
on the disposition of collagen, one of the major components in the formation of
fibrotic tissues, which raised problems in the analysis of the pathogenesis of
muscle dystrophy (Morrison et al., 2005).
The second attempt was based on the discovery of utrophin, which is upregulated in the MDX mouse and can compensate for the absence of dystrophin.
This prompted researchers to generate the dytrophin and utrophin double knockout mouse. Strikingly, the mouse null for the dystrophin and utrophin exhibits
much more severe pathology compared to MDX, closely resembling the
phenotypes in DMD patients, including decreased growth, reduced mobility,
muscle weakness, spinal deformities, cardiomyopathy, myofibrosis and short
lifespan. Therefore, dystrophin and utrophin double knockout mouse has been
proposed to provide new insight into pathogenesis and an effective model to test
therapy for the devastating disease (Deconinck et al., 1997).
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Another attempt came from breeding MDX with telomerase null mouse
according to the hypothesis that the much longer telomere of mouse compared to
that of human confers almost infinite proliferative capacity to satellite cells, which
can fuel muscle regeneration through whole life in mouse. The reduced
proliferative potential of muscle stem cells in the double knockout mice led to
more severe phenotype comparing to MDX alone. Thus, the milder phenotype in
MDX compared to DMD patients could be partially attributable to longer
telomeres. This double mutant mouse may prove useful for explaining the
pathophysiology of DMD and testing the therapeutic intervention for DMD
treatment (Sacco et al., 2010).
Altogether, these modifications to the MDX genetic background add more
biological complexity during the translation of data obtained from mouse to
human, indicating more caution need to be taken in the application.
1.5.4.2 Dog Models
Another important animal model for DMD is the Golden Retriever dog
model. In this model, there is a splice-site mutation located in exon 7 of the
Dystrophin gene, which causes the splicing of exon 7 from dystrophin transcript.
As a consequence, the deletion of exon 7 shifts the open reading frame and
leads to no protein production.
The dystrophic phenotype in this model is so severe that the mutant dogs
die prematurely (Sharp et al., 1992). This model has been utilized primarily as a
reference species to test therapeutic intervention before applied into clinical trial.
However, one problem regarding Golden Retriever dystrophic dogs is that the
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low survival rate makes it not only time-consuming but also very expensive to
generate enough numbers for practical application. Besides, there are also
several distinct phenotypes of muscle dystrophy between Golden Retriever
dystrophic dogs and DMD patients due to the differences between these two
species. For example, some Golden Retriever dystrophic dogs died soon after
birth due to severe phenotype, which is very rare in DMD patients. Still, this
emphasized that the species difference need to be taken into consideration when
applying data gathered from animal model to human beings.
1.6

Signaling Pathways in Postnatal Myogenesis

Muscle regeneration involves a series of orchestrated events that require
extensive communication of multiple signaling pathways and transcriptional
factors during the satellite cell activation and myoblast proliferation/differentiation
as well as myotube formation. To name a few, two classical developmental
signaling pathway, Wnt and Notch, has been corroborated to play pivotal roles in
the myogenic response during muscle regeneration.
1.6.1 Wnt Signaling Pathway
The canonical Wnt activation requires the binding of extracellular Wnt
family glycoproteins with Frizzled receptors and LPR (low-density lipoprotein
receptor-related protein). This interaction can promote the phosphorylation of
Disheveled, which can inhibit GSK3-β activity (GSK3-β phosphorylated at
tyrosine 206) (Yuan et al., 1999). In the cytoplasm, GSK3-β and β-catenin can
form the complex together with Axin and adenomatous polyposis coli (APC), in
which the β–catenin can be phosphorylated by GSK3-β and further degraded by
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proteasome. The inhibition of GSK3-β by phosphorylated Disheveled stabilizes
β–catenin and allows β–catenin to enter the nucleus and interact with TCF/LEF
transcriptional factors to regulate expression of target genes, including MyoD and
myogenin (Church and Francis-West, 2002; Ridgeway et al., 2000) (Figure 1.1).
Wnt signaling pathway regulates a series of biological processes,
including cell morphology, cell adhesion, cell proliferation and cell fate
determination. Because all these processes are highly active in skeletal muscle
regeneration, it is plausible to assume that Wnt signaling pathway plays a key
role in muscle repair. Indeed, mRNA transcripts of Wnt5a, 5b, 7a, and 7b are
elevated at 4 days post cardiotoxin-induced injury (Polesskaya et al., 2003).
Emerging evidences have shown how Wnt is involved in the postnatal
myogenesis during muscle regeneration. However, the results were controversial
between different research groups. Rando group determined that Wnt can
promote myogenic differentiation only in the late stage of myogenesis (Brack et
al., 2008). In contrast, Zammit group suggested that Wnt can promote selfrenewal and inhibit myogenic differentiation by over-expression and knockdown
of β-catenin in single fiber culture (Perez-Ruiz et al., 2008). Taken together, Wnt
signaling pathway does have regulatory effects on postnatal myogenesis during
muscle regeneration. However, further studies should be conducted to
investigate the detailed mechanism.
1.6.2 Notch Signaling Pathway
Activation of Notch signaling pathway require the binding of ligands (Dll1,
3 and Jag1, 2 in mice) to Notch transmembrane receptors (Notch1-4 in mice).
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Consequently, the binding induces the enzymatic cleavage of Notch receptors by
metalloproteases and γ-secretases and then release the active truncated form of
Notch receptors, named as Notch intracellular domain (NICD). Subsequently,
NICD translocates from the cytoplasma to the nucleus, wherein NICD can
interact with the CSL transcriptional repressors (CBF1/RBP-J, Suppressor of
Hairless, and Lag-1) and convert them to transcriptional activators. The complex
of NICD and CSL activates the expression of target genes, including Hes and
Hey family genes (Artavanis-Tsakonas et al., 1999) (Figure 1.2).
During the myogenesis, Notch signaling pathway plays critical roles in
mediating the communication between cells due to their transmembrane location.
Notch receptors including Notch 1, Notch 2 and Notch 3 are all expressed
abundantly in satellite cells (Kitamoto and Hanaoka, 2010). Upon muscle injury,
the expression levels of the Notch 1 receptor together with the Notch ligand Delta
1 are both elevated on satellite cells and their neighbor muscle fibers (Conboy
and Rando, 2002), which promotes the proliferation of satellite cells and inhibit
the myogenic terminal differentiation. Inhibition of Notch by Notch antagonist or
γ-secretase inhibitors leads to decreased proliferation and premature myogenic
differentiation. Due to the lack of myoblast required for muscle regeneration, the
inhibition of Notch deteriorates muscle repair (Kitzmann et al., 2006). Reversely,
activated NICD can directly regulate Pax7 to promote myoblast proliferation and
inhibit myogenic differentiation. As a consequence, constitutive activation of
Notch signaling pathway also spoils muscle regeneration (Wen et al., 2012).
Based on the active participation in muscle regeneration, Notch has provided
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promising avenues for the treatment of muscle diseases. However, extreme
caution should be given to balance its function in myoblast proliferation and
differentiation.
1.6.3 Interplay between Wnt and Notch Signaling Pathways
It is worthy to mention that Wnt and Notch can interplay with each other
during muscle regeneration. In the early stage of myogenesis, Notch can
promote myoblast proliferation and inhibit precocious differentiation. As
myogenesis proceeds, Notch inactivation is necessary for myogenic terminal
differentiation. It has been demonstrated that the activation of Wnt pathway plays
antagonizing effects to Notch to facilitate the terminal differentiation. This is
supported that inactivation of Notch signaling pathway is related to the
dephosphorylation of GSK3-β at the tyrosine 216 site, which is important for the
stabilization of β–catenin and Wnt activation (Conboy and Rando, 2002; Hagen
et al., 2002). Consequently, at day one post muscle injury, when myoblasts
proliferate extensively, Notch activity is high and Wnt activity is weak. While at
day four post injury, myoblasts are ready to enter the terminal differentiation
phase, in which Notch activity decreases and Wnt activity increases (Brack et al.,
2008). Of note, it has been well documented that GSK3-β can directly bind to the
NICD and regulate Notch target gene expression (Espinosa et al., 2003; Foltz et
al., 2002). Thus it appears plausible to conclude that GSK3-β function as a
bridge to connect Wnt and Notch signaling pathways. Therapeutic intervention of
the balance between Wnt and Notch pathways through GSK3-β would be
beneficial for cell fate decision during muscle regeneration.
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1.7

Brain Expressed X-linked Protein 1 (Bex1)

1.7.1 Brain Expressed X-linked Gene Family
Bex1 belongs to the Bex gene family, which is relatively small but may
play essential roles in the development and function in mammals. It was reported
that Bex family was highly expressed at rat embryonic day 10 of development
during ventral mesencephalon development, suggesting the role of Bex family in
the dopamine neuron differentiation (Alvarez et al., 2005). To date, six members
of the Bex family have been discovered, including Bex1Bex1Bex1, Bex2, Bex3,
Bex4, Bex5 and Bex6. Except Bex6, which is in chromosome 16, the other five
members are located in the X chromosome with tandemly arrangement. In detail,
Bex5, Bex1Bex1Bex1 and Bex2 are located in the negative strand while Bex3
and Bex4 in the positive strand tandemly (Zhang, 2008). In addition, the gene
structures of the whole family are well conserved. All of them contain three exons
while the first two exons are not translated.
All the six members of Bex family have been characterized in term of their
sequences and expression pattern in human, mice, and rats (Figure 1.3). For
instance, the amino acid sequences of human Bex1 and Bex2 are almost
identical (85% identity) and both of them are highly expressed in central nervous
system, including pituitary, cerebellum, and temporal lobe (Alvarez et al., 2005).
Bex3, also named as pHGR74 or NADE, has been determined to interact with
low-affinity neurotrophin receptor (p75NTR) to mediate apoptosis signaling
(Mukai et al., 2000). Also, it has been demonstrated that Bex3 is abundantly
expressed in the human ovarian granulose cells (Rapp et al., 1990). Although
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Bex3 is only 30% identical to Bex1 or Bex2 in their sequences, they still share
some major function domains, indicating they may be involved in similar
biological process. Indeed, Bex1, Bex2 and Bex3 are all expressed in the
olfactory system (Behrens et al., 2003). In addition, Bex4 and Bex5 share 54%
and 56% sequence identity with Bex3, respectively. And both of them are very
similar in sequences and are highly expressed in brain. Besides, Bex4 is highly
expressed in heart, skeletal muscle and liver, which may indicate that it is
associated with high energy consumption. Compared to Bex4, Bex5 is more
widely expressed (Alvarez et al., 2005). As a novel member of Bex family, Bex6
is the only one which is not expressed in human. Also Bex6 is not located in X
chromosome but chromosome 16 in mouse, which suggests a distant
relationship with other members. As for the subcellular localization, the six
members of Bex family vary greatly. Bex1 is more confined to the nucleus while
Bex3, Bex5 and Bex6 are expressed in cytoplasm. Bex2 and Bex4 can be
expressed in both nucleus and cytoplasm (Alvarez et al., 2005). Taken together,
the six members of Bex family are highly homologous but different in the
expression pattern as well as the subcellular localization.
1.7.2 Bex1 Structure and Expression Pattern
Bex1 gene is located in the 53.77cM on X chromosome in mouse, which
corresponds to the Xq22 region on human X chromosome. In mouse, the gene
consists of three exons which span around 1.5kb of genomic DNA and the size of
mRNA transcript is around 800bp. There are more transcripts expressed from the
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maternally inherited allele compared with the paternally inherited allele, indicating
an imprinted expression pattern (Brown and Kay, 1999). Bex1 protein has 128
amino acids, including a nuclear localization signal, a histidine-rich sequence
close to the carboxyl terminal and a carboxyl terminal CLMP motif (Behrens et al.,
2003; Brown and Kay, 1999).
In mouse, Bex1 is highly expressed in brain with low levels in lung and
gonads (Brown and Kay, 1999). While in human, northern blot analysis revealed
that the approximately 1kb mRNA transcript is expressed abundantly in brain,
pancreas, ovary and testis while at low levels in heart, placenta, liver, kidney,
thymus, spleen, prostate, small intestine, adrenal gland, thyroid, and spinal cord.
There is no expression in lung, stomach, bone marrow, and skeletal muscles
(Yang et al., 2002). Also, Bex1 was identified with an up-regulation after
fertilization (Williams et al., 2002), indicating that Bex1 may play roles in
embryonic development. Altogether, although the expression pattern was well
characterized, the detailed function of Bex1 remains to be clarified, especially in
some specific tissues.
1.7.3 Bex1 Functions
Bex1 was first identified with reduced expression in the teratocarcinoma
cell line after treatment of retinoic acid and characterized in the analysis of
imprinted genes between parthenogenetic and normal blastocysts (Brown and
Kay, 1999; Faria et al., 1998). Multiple studies have been performed afterwards
to explore the function of Bex1 in many biological processes. Bex family
members are well conserved and the amino acid sequence of Bex1 has 87%

40
identity with Bex2 but lower similarity to other members (30% identity with Bex3,
25% identity with Bex4, 20% identity with Bex5, 18% identity with Bex6). Notably,
some functional domains among the Bex family members are well conserved,
suggesting that these Bex proteins may share the same implication in term of
biological activity. For instance, researchers first found that Bex3 could bind
p75NTR directly to mediate the neurotrophin signaling pathway (Mukai et al.,
2000). Due to the similarity of sequences implicated in the p75NTR binding
between Bex1 and Bex3, it has been proposed and finally confirmed that Bex1
can also bind to p75NTR to play roles in neurotrophin signaling pathway (Vilar et
al., 2006). To date, the functions of Bex1 has been associated with
tumorigenesis, p75NTR mediated cell cycle regulation, neuron regeneration, and
muscle regeneration. However, the molecular mechanism behind Bex1
regulation has remained to be clarified.
1.7.3.1 Bex1 is A Tumor Suppressor.
To date, most Bex1-related studies focus on its contribution in the
formation of various tumors, including pediatric intracranial ependymoma
(Karakoula et al., 2014), oral squamous cell carcinoma (Lee et al., 2013), salivary
gland adenoid cystic carcinoma (Shao et al., 2011), malignant glioma (Foltz et al.,
2006) and so forth. Based on these studies, Bex1 has been determined as a
tumor suppressor. Inactivation of tumor suppressor genes, together with
overexpression of oncogenes, has been regarded as the dominant driving force
of tumorigenesis. Inactivation of tumor suppressor genes can be attributable to
multiple reasons. Epigenetic regulation is one of the reasons and has drawn
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intense interest in the field in the past decades. The most common epigenetic
mechanism implicated in the inactivation of tumor suppressor genes includes
promoter hypermethylation and histone deacetylation. In those aforementioned
Bex1-related tumors, Bex1 was markedly silenced in the tumor specimens by
extensive promoter hypermethylation. Furthermore, Bex1 over-expression can
dramatically inhibit cell proliferation and colony formation.
Besides its role of tumor suppressor in cancer, Bex1 is also essential to
understanding the acquisition of chemoresistance in the progression of multiple
tumors, such as breast cancer and leukemic cells. Chemotherapy can induce cell
apoptosis and has been applied to the treatment of various cancers. Although an
expanding amount of chemotherapy reagents have been developed in the past
decades, chemoresistance of tumor cells still poses a significant challenge in
cancer treatment. The mechanism of chemoresistance has been under intense
investigation. Bex1 down-regulation in cancer cells is a novel mechanism by
which cancer cells can obtain the chemoresistance and escaped apoptosis. In
contrast, ectopic expression of Bex1 can sensitize cell to apoptosis induced by
chemotherapy (Foltz et al., 2006). It has been recently demonstrated that Bex1
can promote imatinib-induced apoptosis through interacting with BCL-2 and
suppressing the formation of anti-apoptotic complex Bcl-2/BAX (Xiao et al., 2014).
Taken together, Bex1 functions as a tumor suppressor and can be a potential
target for cancer therapy.
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1.7.3.2 Bex1 Regulates Cell Cycle through p75NTR.
Understanding the involvement of Bex1 in tumor progression can be
associated with the function of Bex1 in cell cycles. It has been found that Bex1
can prevent normal neuron cell cycling and inhibition of Bex1 in neuron cells can
lead to sustained cell proliferation under the condition of growth arrest. Further
studies have confirmed that Bex1 regulates cell cycle by interacting with p75NTR
to participate in neurotrophin signaling pathway (Vilar et al., 2006).
Neurotrophin signaling pathway has been characterized to regulate cell
survival, growth and differentiation in a variety of neuronal subpopulations. Two
types of receptors are involved in the neurotrophin signaling pathway. One is the
high affinity receptors (Trk tyrosine kinases) while the other is the low affinity
receptors (the p75 neurotrophin receptor, p75NTR). It has been determined that
two Bex family members, Bex1 and Bex3, can interact with p75NTR to initiate
signal transduction (Mukai et al., 2000; Vilar et al., 2006).The binding of
neurotrophin to p75NTR can lead to multiple physiological consequences in the
neuron system, varying from cell apoptosis to neurite survival and even
outgrowth. This is supported by the observation that p75NTR knockout mice
have markedly less sensory neurons but normal motor neurons in dorsal root
ganglia as well as dramatically increased cholinergic neurons in basal forebrain
(Niklison-Chirou et al., 2013). These multifaceted functions of p75NTR signaling
pathway reflects that other factors may be involved in the regulation process.
Furthermore, due to lack of intrinsic catalytic ability of p75NTR receptor,
the signaling pathway is largely dependent on the p75NTR-interacting molecules.
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Because of these different mediators, p75NTR can exert its multiple effects on
cellular activity. For example, p75NTR can inhibit cell mitosis through interacting
with SC1 and promote neurite outgrowth through activating RhoA as well as
induce cell death through NRAGE (Chittka et al., 2004; Salehi et al., 2000; Taylor
et al., 2001). However, the detailed mechanism how the interaction between
p75NTR and interactors with or without catalytic capability mediates downstream
signaling pathway and cellular response needs to be investigated specifically
based on cellular context.
Vilar et al. has demonstrated that Bex1 and p75NTR share essentially
indistinguishable expression pattern in the nervous system as well as vascular
and mesenchymal structures during embryonic development. They continued to
confirm that Bex1 can directly interact with p75NTR intracellular domain (Vilar et
al., 2006). Considering the regulation of p75NTR signaling on the cell cycle and
cell apoptosis, Bex1 expression levels may have great implication in the
intracellular machinery controlling cell survival, proliferation and differentiation.
1.7.3.3 Bex1 Regulates Neuron Regeneration.
Regeneration in neuron system could be complicated partially due to the
different regeneration capacity based on different location. In detail, axons in
peripheral neuron system can be repaired after injury while axons in central
neuron system do not preserve any regeneration capability. This difference can
be attributable to both intrinsic and extrinsic factors. Axons in central neuron
system are intrinsically lack of ability of regrowth. Besides, a variety of extrinsic
factors in the central neuron system can be released to inhibit the regrowth, such
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as myelin-associated glycoprotein (MAG) (McKerracher et al., 1994; Richardson
et al., 1980). In contrast, the injured axons in peripheral neuron system can not
only induce the intrinsic capacity of neuron regrowth but also stimulate multiple
extrinsic regeneration-related gene expression to overcome the blockage of
inhibitory factors .
Bex1 has been identified as one of the extrinsic regeneration genes, which
is indicated by the observation that the expression level of Bex1 was elevated
after axon injury as well as that Bex1 expression is consistent with several
established regeneration genes in multiple mouse models. Also Bex1 knockout
mice are deficient in axon regeneration after sciatic-nerve injury, a wellestablished model for studying neuron regeneration. Furthermore, Bex1 can
counteract the inhibition of inhibitory factors during axon regeneration in that the
motor neuron expressing Bex1 can grow longer axon than wild type in the
presence of MAG. Therefore, Bex1 can be categorized as a regeneration gene
during peripheral neuron repair (Khazaei et al., 2010).
To date, the mechanism of Bex1 involvement in the axon regeneration at
the molecular level remains elusive. It was hypothesized that the interaction
between Bex1 and p75NTR signaling pathway may be conducive to
understanding the mechanism as p75NTR signaling pathway can regulate
neuron cell growth and differentiation as well as p75NTR also interacts with MAG
(Dubreuil et al., 2003; Robak et al., 2009; Vilar et al., 2006). Future endeavors
need to be attempted to investigate the role of Bex1 in the neuron regeneration.
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1.7.3.4 Bex1 Regulates Muscle Regeneration.
The relevance of Bex1 in muscle regeneration was discovered in a
microarray aimed to identify a panel of genes with altered expression in CTX
induced muscle injury, a well-established model for muscle regeneration (Yan et
al., 2003). Consistently, the expression level of Bex1 was dysregulated in MDX
mice (Turk et al., 2005), which undergo progressive muscle degeneration and
regeneration. Bex1 knockout mice have prolonged proliferation and delayed
differentiation kinetics. In addition, both cell cycle inhibitor genes and myogenic
differentiation marker myogenin were down-regulated compared to regenerating
wild type muscles (Koo et al., 2007).
It has been suggested that Bex1 regulates muscle regeneration through
interacting with calmodulin (CaM) (Koo et al., 2007). And Bex1 and CaM colocalize in myogenic cells during muscle regeneration (Koo, 2010). CaM can bind
calcium to activate calcium dependent kinases and initiate calcium signaling
pathway. Due to the indispensable role of calcium in myogenesis, it is logical to
hypothesize that the interaction between Bex1 and CaM contributes to muscle
regeneration. Moreover, one can speculate that the interaction between Bex1
and p75NTR also contributes to the regeneration of skeletal muscles since
p75NTR is also highly expressed in myogenic cells (Lomen-Hoerth and Shooter,
1995; Yamamoto et al., 1996). Besides, given that muscle regeneration is a
complicated process which requires a series of coordinated responses from
surrounding cells, this hypothesis is also supported by the observation that
neurotrophins are secreted by various cells in the developing limb bud
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(Henderson et al., 1993; Ip et al., 2001). Furthermore, analysis of their
expression pattern during embryonic development shows that Bex1 and p75NTR
can be concomitantly expressed in the somatic mesenchyme and heart (Cotrina
et al., 2000; von Schack et al., 2001), suggesting that Bex1 could interact with
neurotrophin signaling pathway in muscle regeneration. However, detailed
mechanism underlying Bex1’s function in satellite cells and muscle regeneration
remains to be clarified.
1.8

Rationale and Objectives

Under normal conditions, skeletal muscles are very stable with little
myonuclei turnover. However, skeletal muscles are susceptible to injury, which
may lead to mass loss and functional deficiency. Skeletal muscles have a
remarkable capacity to initiate the repairing process, muscle regeneration, to
prevent further muscle loss and maintain normal muscle function. The overall aim
of this dissertation is to study muscle regeneration process at the cellular and
molecular level. In detail, two projects are included in this dissertation. The first
one is to investigate how Notch signaling pathway regulates satellite cells
behavior and further affects skeletal muscle regeneration in MDX mice. The
second one is to explore the role of Bex1 in the myogenesis as well as muscle
regeneration. This Chapter mainly reviews the current knowledge related to
these two objectives. Satellite cells, which play an essential role in muscle
regeneration, are emphasized. Importantly, it is worthy reviewing the knowledge
related to MDX, the widely used mouse model for Duchenne muscle dystrophy,
which is characterized by progressive muscle degeneration and regeneration.
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Besides, a number of signaling pathways and transcriptional factors have been
demonstrated to regulate muscle regeneration. In particular, Notch signaling
pathway and Bex1 are discussed in more details to provide a comprehensive
understanding in the follow-up experiments.
Muscle regeneration is a perfect model to study skeletal muscle stem cell
biology in that it can facilitate exploring not only basic mechanisms of muscle
development but also the therapeutic potentials of muscle stem cells. Therefore,
unraveling the regulatory network behind muscle regeneration has drawn intense
research attention in the field. To date, great progress has been made in
understanding muscle regeneration, yet there are many unanswered question
and unexplored areas. With this notion in mind, the roles of Notch signaling
pathway and Bex1 gene in muscle regeneration were investigated in this
dissertation. Notch signaling pathway plays multifaceted roles in the myogenesis.
In particular, Notch can promote the self-renewal capacity of satellite cells, the
predominant cellular source for muscle regeneration. Whether promoting satellite
cell self-renewal contributes to muscle regeneration is an intriguing question. If
so, enhancing satellite cell self-renewal may lead to improved muscle function in
various degenerative and congenital muscle diseases, such as Duchenne
muscular dystrophy. Next, Bex1 has been implicated in regeneration of motor
neuron and skeletal muscles. However, the role of Bex1 in myogenic satellite
cells and the underlying mechanisms remain to be elucidated. Several findings
related to the function of other Bex family members may open new perspectives
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in understanding the molecular mechanism of Bex1 regulation in muscle
regeneration.
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Table 1 1 Characteristics of Different Types of Muscle Fibers
Fiber Types
Characteristics

Slow

Fast

Contraction

Slow

Fast

Resistance to fatigue

High

Low

Generation of ATP

Aerobic

Anaerobic

Amount of Mitochondria

High

Low

Oxidative Capacity

High

Low

Glycolytic Capacity

Low

High
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Figure 1.1 A Diagram of the Canonical Wnt Signaling Pathway
In the absence of Wnt ligands, β-catenin can interact with GSK3-β, Axin and
APC and form a multi-protein complex, in which β-catenin can be phosphorylated
and further degraded by the proteasome. Without β-catenin translocation to the
nucleus, TCF/LEF transcriptional factors will be bound by the repressors, which
blocks the gene transcription. While the binding of Wnt ligands to the receptors
can activate Disheveled, which blocks the multi-protein complex formation and
phosphorylation of β-catenin. Therefore, β-catenin can be translocated to the
nucleus and bind to the TCF/LEF, which initiates the transcription.
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Figure 1.2 A Diagram of the Canonical Notch Signaling Pathway
Notch receptors and ligands are both expressed in the ccell
ell membranes. Upon the
binding of Notch ligands, Notch receptors can be cleaved by metalloproteases
and γ-secretases, which produces the active Notch intracellular domain, named
as NICD. NICD can be translocated into nucleus and bind to CSL, which
converts CSL from transcription repressor to transcription activator and
subsequently initiates the gene transcription.
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Figure 1.3 Alignment of the amino acid sequences of Bex proteins
Shown are the amino acid sequences comparison of human Bex1, Bex2, Bex3,
Bex4, Bex5 and mouse Bex6. Red color represents high consensus, Blue color
represents low consensus, and black represents neutral. Figures generated from
the multialin website, http://multalin.toulouse.inra.fr/multalin/.
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CHAPTER 2. NOTCH SIGNALING DEFICIENCY UNDERLIES AGEDEPENDENT DEPLETION OF SATELLITE CELLS IN MUSCULAR
DYSTROPHY

Previously published by Disease Models and Mechanisms in Aug 2014

2.1

Abstract

Duchenne Muscular Dystrophy (DMD) is a devastating disease
characterized by muscle wasting, loss of mobility and early death. Satellite cells
are muscle-resident stem cells responsible for the repair and regeneration of
damaged muscles. One pathological feature of DMD is the progressive depletion
of satellite cells, leading to the failure of muscle repair. Here I attempted to
explore the molecular mechanisms underlying satellite cell ablation in the
Dystrophin mutant MDX mouse, a well-established model for DMD. Initial muscle
degeneration activates satellite cells, resulting in increased satellite cell number
in young MDX mice. This is followed by rapid loss of satellite cells with age due
to reduced self-renewal ability of MDX satellite cells. In addition, satellite cell
composition is altered even in young MDX mice, with significant reductions in the
abundance of non-committed Pax7+/Myf5- satellite cells. Using a Notch-reporter
mouse, I found that the MDX satellite cells have reduced activation of Notch
signaling, which has been shown to be necessary to maintain satellite cell
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quiescence and self-renewal. Concomitantly, the expression of Notch1, Notch3,
Jag1, Hey1 and HeyL are reduced in the MDX primary myoblast. Finally, I
established a mouse model to constitutively activate Notch signaling in satellite
cells, and show that Notch activation is sufficient to rescue the self-renewal
deficiencies of MDX satellite cells. These results demonstrate that Notch
signaling is essential for maintaining the satellite cell pool and its deficiency leads
to depletion of satellite cells in DMD.
Keywords: Muscular Dystrophy, Notch Signaling, Stem cells
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2.2

Introduction

Muscular dystrophies include a spectrum of inherited diseases leading to
progressive muscle degeneration and dysfunction (Wallace and McNally, 2009).
The most severe and common form of muscular dystrophy is Duchenne
Muscular Dystrophy (DMD). DMD is a devastating recessive X-linked muscle
degenerative disease caused by frame shift deletions, duplications, or point
mutations in the Dystrophin (DMD) gene (Hoffman et al., 1987; Worton et al.,
1984). Dystrophin is a cytoskeletal protein that interacts with a group of
peripheral membrane and transmembrane proteins, such as dystroglycan and
sarcoglycan, to form the dystrophin-associated protein complex (DAPC)
(Matsumura et al., 1994). The DAPC provides a linkage between the
cytoskeleton and extracellular matrix of muscle fibers, and maintains the integrity
of sarcolemma (muscle membrane) during muscle contraction (Ervasti and
Sonnemann, 2008). Absence of Dystrophin results in the disassociation of the
DAPC. As a consequence, the sarcolemma becomes fragile to mechanical
damages, and normal muscle activity would result in muscle degeneration,
chronic inflammation and fibrosis (Petrof et al., 1993). These pathological
stimulations alter the tissue environment and compromise muscle function to
further deteriorate the dystrophic phenotype. DMD patients typically suffer from
rapid progression of muscle degeneration, and are eventually paralyzed and die
in their second to third decade of life.
Skeletal muscles have a remarkable capacity to regenerate. This capacity
is mainly attributed to a stem cell population called satellite cells. Satellite cells
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are muscle-specific adult stem cells responsible for muscle regeneration in
response to injuries . Upon a muscle injury, satellite cells, located between the
basal lamina (i. e. the muscle extracellular matrix) and sarcolemma, are activated
from quiescence and proliferate as myogenic precursor cells, the proliferating
myoblasts then undergo either self-renewal and return to quiescence, or
differentiation to form functional muscles (Anderson, 2006; Cheung and Rando,
2013; Kuang and Rudnicki, 2008; Wagers and Conboy, 2005). In healthy
humans, satellite cells can proliferate and repair muscle damage. However,
unrelenting muscle degeneration in DMD puts satellite cells in a constant
activation mode and eventually depletes the satellite cell pool, leading to the
failure of muscle repair and accelerated disease progression (Blau et al., 1983;
Blau et al., 1985; Heslop et al., 2000).
Currently, there is no effective treatment for DMD patients. To date, stem cell –
based therapeutic strategies are under intense investigations. The stem cell
therapies mainly include delivery of exogenous muscle stem cells to boost the
regeneration of DMD muscles, and functional enhancement of endogenous
muscle stem cells (Bentzinger et al., 2010; Quattrocelli et al., 2010; Shi and
Garry, 2006). However, stem cell therapies are still in their infancy and to achieve
the full potential of these regenerative approaches, it is necessary to better
understand the cellular and molecular mechanisms governing satellite cell
behavior and function. Previous studies have shown that Notch signaling
pathway plays important roles in maintaining satellite cell quiescence as well as
regulating proliferation and differentiation (Bjornson et al., 2012; Buas and
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Kadesch, 2010; Conboy and Rando, 2002; Mourikis et al., 2012). Constitutive
activation of Notch pathway promotes the self-renewal of satellite cells by upregulating Pax7, a key regulator of satellite cell identity (Wen et al., 2012).
Conversely, blockage of Notch signaling in satellite cells results in muscular
dystrophy characteristics and impairs muscle regeneration (Lin et al., 2013).
However, whether Notch signaling is deregulated in satellite cells of dystrophic
muscles and whether it contributes to the progression of muscle degeneration
have not been determined.
In this study, I aimed to address these questions using the MDX mouse
model (Bulfield et al., 1984), which carries a mutation in the Dmd gene and thus
has been widely used as an animal model for human DMD (Partridge, 2013). I
discovered that MDX satellite cells exhibit defective self-renewal capacity
associated with attenuated Notch signaling transduction. Importantly, constitutive
activation of Notch signaling in the MDX satellite cells rescued their self-renewal
defects. These data demonstrate that the attenuated Notch signaling in MDX
leads to satellite cell dysfunction, and further suggest that Notch signaling
preserves therapeutic potential to retain the self-renewal capacity in dystrophic
muscles.
2.3

Materials and Methods
2.3.1 Animals

Myf5nLacZ mice were provided by Shahragim Tajbakhsh (Christov et al.,
2007). All other mice are available from Jackson Laboratories (ROSA26-N1ICD
stock number 008159 and MDX stock number 001801, Pax7-CreER stock

58
number 012476, CpGFP stock number 005854). Mice were maintained in a clean
mouse facility at Purdue University. All procedures involving animal maintenance
and experimental use were performed according to the guidelines presented by
Purdue University’s Animal Care and Use Committee.
2.3.2 Muscle Injury and Regeneration
Muscle regeneration was induced by Cardiotoxin (CTX; Sigma-Aldrich, St.
Louis, MO) injection. Mice were first anesthetized using a ketamine-xylazine
cocktail, and then 50ul of 10 mM CTX was injected into the Tibialis Anterior (TA)
muscle. Muscles were harvested at 7 days post injection.
2.3.3 Electroporation of DNA Plasmids into TA Muscles
About 10 µl of empty pEF-BOS Neo plasmid, Jag1 plasmid, or RAMIC
domain (NICD) plasmid were injected at a concentration of 0.5 µg/µl (in 0.9%
NaCl) into TA muscles along the whole muscle length. Two spatula electrodes
were then placed on each side of the muscle belly, and eight pulses (20 ms 200
V/cm) at 1 second intervals were applied to the electrodes controlled by a BTX
ECM 830 electroporator (Genetronics, San Diego, CA). The dosage was
established in a preliminary study using the GFP plasmid, in which ~70%
myofibers in the vicinity of the injection site and ~30% fibers in the whole muscle
were GFP+ at 1 week after electroporation. Using this protocol, Jag1 or RAMIC
was electroporated into the left TA muscles of the Cp-GFP mice, and the empty
pEF-BOS vector was electroporated into the contralateral (right) TA as control.
One week after electroporation, the TA muscles were harvested for assessment
of Cp-GFP and Pax7 expression by immunohistochemistry.
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2.3.4 Isolation and Culture of Single Fibers and Primary Myoblast
Single myofibers were isolated from the Extensor Digitorum Longus (EDL)
muscles after collagenase A (Sigma) digestion for 45 min to 1 hour. Suspended
fibers were collected and cultured in horse serum-coated plates in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bovine serum (FBS;
HyClone, Logan, UT), 2% chicken embryo extract (Accurate Chemical, Westbury,
NY), and 1% penicillin-streptomycin for 72hs.
Primary myoblast was collected from limb skeletal muscle. These muscles
were minced and digested with a cocktail of type I collagenase and Dispase B
mixture. Debris was removed using filters from cells. Primary myoblast was
cultured in 100mm collagen coated plates in the growth medium (F-10 Ham’s
medium supplemented with 20% FBS, 4 ng/ml basic fibroblast growth factor, and
1% penicillin-streptomycin) at 37°C, 5% CO 2.
2.3.5 Fluorescent Activated Cell Sorting
Cells were isolated from hindlimb muscles of 6- to 8-week-old mice.
Erythrocytes were removed through the Red Blood Cell Lysing Buffer Hybri-Max
(Sigma). Mononuclear cells were blocked with goat serum for 10 min and
incubated with primary antibodies in DMEM with 2% FBS at 1–3 × 107 cell/ml for
15 min at 4℃. Cells were briefly washed and incubated with appropriate
secondary antibodies (1: 1000) at 4℃ for 15 min. After staining, cells were
washed, passed through 30 µm filters (Miltenyi Biotec) and suspended at a
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concentration of 1 ×107 cells/ml. Cells were separated on a MoFlo cytometer
(DakoCytomation) equipped with three lasers. Sorting gates were strictly defined
based on single antibody-stained control cells as well as the forward and SSC
patterns of satellite cells based on preliminary tests.
2.3.6 Cryosection
Fresh TA muscles were embedded in optimal cutting temperature (OCT)
compound (Sakura Finetek) and immediately frozen in dry ice-cooled isopentane.
Muscle blocks were cut by 10um with a Leica CM 1850 cryostat instrument. The
sections were placed on Superfrost Plus glass slides (Electron Microscopy
Sciences).
2.3.7 Immunostaining and Image Capture
Muscle fibers and tissue sections were first fixed in 4% PFA and blocked
in the blocking buffer containing PBS, 5% horse serum, 2% bovine serum
albumin, 0.2% Triton X-100 and 0.1% sodium azide for 60mins. Then the fibers
and sections were incubated with primary antibodies diluted in blocking buffer
overnight at 4℃, then incubated with secondary antibodies and Hoechst diluted
in PBS for 30 minutes at room temperature, and mounted with Dako fluorescent
mounting media (Glostrup, Denmark). Fluorescent pictures were taken with a
Coolsnap HQ CCD camera (Photometrics, USA) driven by IP Lab software
(Scanalytics, USA) in a Leica DMI 6000B fluorescent microscope (Mannheim,
Germany). As the analysis of the immunofluorescence was qualitative, identical
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image handling and fluorescence scoring criteria were applied in all the
experiments.
2.3.8 Quantitative Real-time Polymerase Chain Reaction (qPCR)
RNA was extracted and purified from wild type and MDX primary myoblast
cell cultures using Trizol. Random hexamer primers were used for the reverse
transcription from RNA to cDNA. qPCR was performed with a Light Cycler 480
machine (Roche). 18s was used as housekeeping gene for normalization. For
qPCR result analysis, 2-ΔΔct method was applied to calculate the fold change.
2.3.9 Statistical Analysis
The data are displayed with mean ± s.e.m. P-values were calculated by
two-tailed Student’s t-test. P-values <0.05 were considered to be statistically
significant.
2.4

Results

2.4.1 Satellite Cell number and Activity Decline with Age in MDX Mice.
As satellite cells are necessary for postnatal muscle regeneration (Lepper
et al., 2011; Murphy et al., 2011; Sambasivan et al., 2011), I aimed to examine
satellite cell behavior in MDX mice whose muscles are under repetitive
degeneration and regeneration. I first examined the abundance of satellite cells
associated with freshly isolated myofibers from the Extensor Digitorum Longus
(EDL) muscles of WT and MDX mice at different ages (Figure 2.1A).
Interestingly, there were significantly more Pax7+ satellite cells per myofiber in
the MDX than WT mice at 2-, 6- and 12-month-old (Figure 2.1B). Whereas the
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number of WT satellite cells continually decline with age at a slow rate, the MDX
satellite cell number initially increases from 1-month-age to 6-month-age,
followed by rapid decline afterwards (Figure 2.1B). As the severity of muscle
pathology starts at approximately 2 months of age in mice (Bulfield et al., 1984),
the initial increases in satellite cell number reflect the activation of satellite cells
due to ongoing muscle injuries. The rapid decline of satellite cell number starting
at 6 months of age suggests that the MDX satellite cells are unable to maintain a
proper balance of proliferation, self-renewal and differentiation.
I further examined the proliferative activity of satellite cells in vivo and in
vitro. In response to cardiotoxin (CTX)-induced muscle degeneration, satellite
cells are activated and proliferate, then fuse to repair the injury. At Day 5 post
CTX injection into TA muscles, the number of satellite cells per myofiber
increased in both WT and MDX mice at 1-6 months of age (Figure 2.1C).
However, the CTX-stimulated fold increases of satellite cells rapidly decreased
with age in the MDX, but not in the WT mice (Figure 2.1D). These results
indicate severe age-dependent deficiencies in the activation and/or proliferation
of satellite cells in the MDX mice. I also cultured satellite cells while they are still
attached on their host myofibers that were singly dissociated from 12 and 24month-old mice (Figure 2.1E). After 72h in culture, the WT satellite cells
proliferated and formed clusters of cells, but the MDX satellite cells in both 12
and 24-month-old mice failed to form cell clusters (Figure 2.1F). This observation
confirms that satellite cell activity declines dramatically in aged MDX mice.
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2.4.2 MDX Satellite Cells Have Reduced Self-renewal Capacity.
Self-renewal is a defining feature of all stem cells and necessary for
maintaining the homeostasis of stem cells. I hypothesized that the agedependent depletion of satellite cells in the MDX mice is due to a reduced selfrenewal capacity. To test the hypothesis, I established the Myf5nLacZ/MDX mice
by breeding MDX mice with Myf5nLacZ mice that marks Myf5-expressing cells by
nuclear localized β-galactosidase (Christov et al., 2007). Previous studies have
shown that Pax7+Myf5- satellite cells give rise to Pax7+Myf5+ satellite cells during
myogenic commitment, and the Pax7+Myf5- cells have higher self-renewal
capacity (Kuang et al., 2007). I isolated EDL myofibers from WT (Myf5+/+/MDX)
and MDX (Myf5nLacZ/+/MDX) mice that were injected with CTX to assure satellite
cells in both WT and MDX mice were in the same activated state. Satellite cells
were then labeled with antibodies to Pax7 and β-gal (Figure 2.2A). In the
absence of CTX-induced injury, similar proportions of Pax7+Myf5- (β-gal-) satellite
cells were found between WT and MDX mice, at both 2 and 6 months of age
(Figure 2.2B). After CTX-induced muscle injury, the abundance of Pax7+Myf5satellite cells was reduced in the MDX mice at both 2- and 6-month-old (Figure
2.2C). Furthermore, the CTX-induced fold change of Pax7+Myf5- satellite cells
was decreased in MDX compared to WT mice at both 2 and 6 months of age
(Figure 2.2D). These in vivo data demonstrate that there is a self-renewal defect
in MDX satellite cells.
I further examined satellite cell self-renewal using a well-established
paradigm involving culture of dissociated myofibers (Halevy et al., 2004; Olguin
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and Olwin, 2004; Zammit et al., 2004). After culture, the self-renewal,
proliferation and differentiation progenies can be distinguished as Pax7+MyoD-,
Pax7+MyoD+ and Pax7-MyoD+, respectively, based on their Pax7 and MyoD
expression pattern (Figure 2.2E). Quantitative analysis indicates that the
percentage of Pax7+MyoD- (self-renewal) cells was drastically decreased in MDX
myofiber cutlures (37% in WT vs 20% in MDX), while the percentage of
Pax7+MyoD+ (proliferating) cells was increased in the MDX and the percentage
of Pax7-MyoD+ (differentiating) cells was not different between WT and MDX
(Figure 2.2F). Moreover, the expression of MyoG, a terminal differentiation
marker of myogenesis, was examined after 72 hours myofiber culture (Figure
2.2G). Quantitative analysis revealed that the ratio of MyoG+/MyoD+ cells was
elavated in MDX at both 2 and 6 months of age (Figure 2.2H), suggesting that
MDX satellite cells have a higher tendency for terminal differentiation.
Collectively, these cell culture data are consistent with the notion that the MDX
satellite cells have reduced self-renewal capacity.
2.4.3 The Notch Signaling Pathway Is Perturbed in MDX Satellite Cells
To understand the molecular mechanism underlying the reduced selfrenewal capacity in the MDX satellite cells, I investigated the Notch signaling
pathway, which has been shown to mediate satellite cell self-renwal and
quiescence (Vasyutina et al., 2007). I detected that the expression of genes
related to Notch signaling pathway was reduced dramatically at both young
(Figure 2.3A) and old (Figure 2.3B) MDX muscles. Strikingly, the reduction was
much more robust in the old (12-month-old) MDX mice (Figure 2.3B compared
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to Figure 2.3A). The reduced expression of Notch receptors, ligands and target
genes in MDX muscles indicate an impairment of Notch signaling transduction.
To directly visualize the activation status of Notch signaling in satellite
cells, I used the Cp-GFP reporter mouse (Mizutani et al., 2007). In this transgenic
mouse, GFP expression is driven by 4 tandem repeats of DNA sequence
recognized by Rbpjk, the nuclear mediator of Notch signaling. When Notch is not
activated, Rbpjk binds to transcriptional repressors which suppress GFP
expression. Upon activation (ligand binding), Notch intracellular domain (NICD)
would detach and translocate to the nucleus, where it replaces the transcriptional
repressors on Rbpjk and activates GFP expression. To establish the utility of this
model in satellite cells, single myofibers were isolated from the Cp-GFP mice and
GFP and Pax7 expression was examined (Figure 2.3C-a). A fraction (~17%) of
Pax7+ satellite cells was GFP+ (Figure 2.3C-b). Next, fluorescent activated cell
sorting (FACS) was used to isolate GFP+ and GFP- satellite cells using α7Integrin (Int-α7) as a positive selection marker for satellite cells (Figure 2.3C-c).
Analysis of FACS-purified satellite cells indicates that 8% freshly sorting satellite
cells (Lin-Int-α7+) were also GFP+ (Figure 2.3C-d). Importantly, the FACSpurified GFP+ satellite cells expressed higher levels of Hes1 (Figure 2.3C-e), a
canonical target of Notch signaling pathway. To further examine if the Cp-GFP
reporter responds to Notch activation in vivo, the DNA plasmids encoding a
Notch ligand (Jag1) or activated Notch (NICD, also called RAMIC domain) were
electroporated in the TA muscles, and Pax7 and GFP expressions were
analyzed 7 days later (Figure 2.3C-f to Figure 2.3C-h). Overall, Jag1
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overexpression increased the percentage of Pax7+/GFP+ satellite cells by ~30%
(n=1,191 cells analyzed) and NICD overexpression increased the double positive
satellite cells by ~50% ( n= 825 cells analyzed). Thus, the Cp-GFP reporter
mouse faithfully reports Notch signaling activation in satellite cells. The single
fiber and FACS analyses further demonstrate that Notch signaling is activated in
a small population of quiescent satellite cells.
I next established the Cp-GFP/MDX mouse model through crossing the
two lines of mice and examined Cp-GFP expression. EDL myofibers were
isolated from WT control (Cp-GFP/WT) and MDX (Cp-GFP/MDX) mice 5 days
after CTX-induced regeneration, and labeled with Pax7 and GFP antibodies
(Figure 2.3D). Notably, the percentage of GFP+ satellite cells (%
GFP+Pax7+/total Pax7+) in MDX was only about half of that in WT mice after CTX
injury(Figure 2. 3L; 37% in WT vs 20% in MDX). By contrast, there was no
significant difference in the percentage of GFP+ satellite cells between WT and
MDX mice under resting conditions (Figure 2.3E). This result suggests that MDX
satellite cells have reduced activation of Notch signaling during muscle
regeneration. Consistent with this notion, mRNA levels of Notch receptors
(Notch1 and Notch3) and Notch ligand (Jagged1) as well as Notch target (HeyL)
were reduced by ~50% in primary myoblasts derived from MDX mice compared
to those from WT mice (Figure 2.3F). Taken together, the self-renewal defects of
MDX satellite cells is associated with reduced Notch signaling transduction.
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2.4.4 Constitutive Activation of Notch Rescues the Self-renewal Defects of
Satellite Cells but Fails to Improve Muscle Pathology in MDX Mice
To directly address whether reduced Notch signaling in MDX satellite cells
is responsible for their self-renewal defects, I carried out gain-of-function studies
using Cre/LoxP mediated conditional gene expression tools. I first cultured EDL
myofibers from Rosa26NICD/MDX mice, and used Adenovirus-Cre to activate
NICD expression during the culture. After 72 h of culture, myofibers were stained
with Pax7 and MyoD (Figure 2.4A). Quantitative analysis indicates that the
percentage of Pax7+MyoD- (self-renewal) satellite cells was drastically increased
(from 12% to 32%) after Cre induced Notch activation, compared to the control
Adenovirus-GFP treatment (Figure 2.4B). Meanwhile the ratio of proliferating
(Pax7+MyoD+) cells was significantly decreased by Notch activation (Figure
2.4B). These results demonstrate that Notch activation improves self-renewal
and inhibits the proliferation of satellite cells in MDX mice.
I next attempted to activate Notch signaling in MDX satellite cells in vivo. To
do this, I established the Pax7CreER/Rosa26NICD/MDX triple transgenic mouse in
which Notch signaling is specifically activated in MDX satellite cells upon
Tamoxifen induction. After 5 doses of Tamoxifen injection, NICD (revealed by
nuclear GFP expression as the Rosa26NICD mice also expression nuclear GFP
upon Cre treatment) was specifically activated in the Pax7+ satellite cells (Figure
2.4C). Analysis of TA muscle cross sections (Figure 2.4D) indicates that the
number of Pax7+ satellite cells was increased significantly after Notch activation
(Figure 2.4E). More strikingly, the percentage of Pax7+MyoD- (self-renewal)

68
satellite cells was also significantly increased (from 40% to 60%) after NICD
overexpression (Figure 2.4F). These results provide compelling evidence that
constitutive activation of Notch rescues the self-renewal defect of MDX satellite
cells.
To examine how satellite cell-specific stimulation of Notch signaling affects
muscle pathology in MDX mice, I conducted histological analysis of TA muscles
sections with and without CTX injury. Surprisingly, Notch activation in satellite
cells failed to ameliorate muscle pathology and improve CTX-induced muscle
regeneration in the MDX mice (Figure 2.4G). This is manifested by the reduced
number of myofibers with an area of 500μm2 or greater (Figure 2.4H). This
observation is consistent with our recent report that constitutive Notch activation
in satellite cells blocked muscle regeneration in WT mice (Wen et al., 2012), due
to the well-known function of Notch signaling in inhibiting myogenic differentiation
(Kopan et al., 1994). These data suggest that although constitutive Notch
activation promotes self-renewal of satellite cells and increases satellite cell
number in MDX mice, Notch signaling must be temporally suppressed during
myogenic differentiation to allow proper progression of myogenesis.
2.5

Discussions

In this work, I identify that the satellite cells in MDX mice undergoes drastic
change not only in the cell number but also in the cell activity. Specifically, the
satellite cells in dystrophic muscles were defective in self-renewal capacity. Also,
I verify that the Notch signaling pathway was perturbed in MDX satellite cells
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using Notch reporter mice. Furthermore, I show that constitutive activation of
Notch signaling rescued the self-renewal deficiency of MDX satellite cells in vitro
and in vivo. However, constitutive activation of Notch failed to improve muscle
regeneration in MDX mice. Nevertheless, these results suggest that aberrant
Notch signaling is responsible for the defective self-renewal capacity and
enhancement of Notch signaling leads to improved self-renewal of satellite cells
in muscular dystrophy.
Muscular dystrophy has been characterized as an inherited disease
featuring susceptibility to muscle damage and progressive muscle wasting. Given
the indispensable role of satellite cells in muscle regeneration (Sambasivan et al.,
2011; von Maltzahn et al., 2013) , the behavior of satellite cells, especially their
replicative and differentiation capacity, determines the progression of muscle
dystrophies. Primary myoblasts isolated from DMD patients have a significant
low yield (Blau, 1983) and reduced proliferative capacity (Lamperth et al., 1990).
Correspondingly, primary myoblasts from MDX mice exhibits accelerated
differentiation kinetics (Yablonka-Reuveni and Anderson, 2006), supporting the
notion that the proliferative capacity was compromised in the satellite cells in
dystrophic muscles. Our results that the satellite cell number and proliferative
response to CTX-stimulation declined with age in MDX mice provide direct in vivo
evidence for age-dependent deficiencies in satellite cell activity.
Our findings that satellite cells in dystrophic muscles are defective in selfrenewal capability are consistent with the previous study that muscle dystrophy
results from an autonomous failure of satellite cells to maintain repetitive
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degeneration and regeneration cycles (Sacco et al., 2010). It is worth mentioning
that murine somatic cells have longer telomeres compared to human cells, which
significantly decreases the replicative senescence and increase the regenerative
capacity of MDX satellite cells (compared to DMD satellite cells). To some extent,
this explains why the MDX mice have slower pathological progression relative to
human DMD. However, our results indicated that the satellite cells in MDX mice
still exhibit deficiencies in self-renewal capability. Specifically, old MDX satellite
cells cannot replenish themselves at all in 24-month-old, while the WT nondystrophic satellite cells can still self-renewal (but at a significantly reduced rate
compared to satellite cells from young animals). This finding prompted us to
investigate the molecular mechanism behind the defective self-renewal capacity
of MDX satellite cells. The mechanism governing the self-renewal of satellite
cells is currently a topic of intense investigation. Recent studies have revealed a
number factors that induce the quiescence/self-renewal of satellite cells. These
include Sprouty1 (Shea et al., 2010), Angiopoietin 1 (Ang1) / Tie2 pathway
(Abou-Khalil et al., 2009), Par-complex-dependent p38α/β MAPK pathway (Troy
et al., 2012), microRNA-489 (Cheung et al., 2012), and nitric oxide (Buono et al.,
2012). However, what signaling mechanism(s) regulate the self-renewal
deficiency in MDX satellite cells has not been determined.
The Notch signaling pathway plays complicated and critical roles in
embryonic muscle development and postnatal myogenesis. Previous studies
have demonstrated an interaction between Dystrophin and Notch pathway. In
Drosophila, the membrane Dystrophin/Dystroglycan complex can interplay with
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the Notch ligand Delta (Kucherenko et al., 2008), which implies that the Notch
signaling pathway may be perturbed in the absence of Dystrophin in MDX
muscles. This notion was supported by the microarray analysis of dystrophic
muscles. A number of key genes involved in the Notch signaling pathway have
been detected with altered levels in dystrophic muscles. Specifically, the Notch
antagonist Numb is up-regulated while the Notch target genes Hes1 and Hey1
are down-regulated drastically (Turk et al., 2005). Most recently, Church et al
discovered a reduction of Notch1 and Hes1 mRNA level in the TA muscles of
MDX mice and DMD patients (Church et al., 2014). However, direct in vivo
evidence demonstrating an aberrant Notch signaling occurs in satellite cells in
dystrophic muscles has been lacking. Using Cp-GFP as a reporter of the Notch
signaling pathway activation, I now provide in vivo evidence that the Notch
signaling pathway is perturbed in satellite cells of MDX muscles. This is the first
direct in vivo evidence that the Notch signaling pathway was inhibited in satellite
cells of dystrophic muscles. Our finding is consistent with the previous studies
that Notch blockage in satellite cells can cause muscle dystrophic phenotype as
well as deteriorated muscle regeneration (Lin et al., 2013). In addition, Church et
al also show that Notch inhibition impeded the functional recovery of regenerated
MDX muscles (Church et al., 2014). To rescue this self-renewal defect in
dystrophic muscles, I established a mouse model to constitutively activate Notch
signaling in satellite cells. As expected, Notch activation successfully ameliorated
the self-renewal capacity, which corroborates that the impaired Notch signaling
pathway contributes to the defective self-renewal capacity in the satellite cells of
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dystrophic muscles. Therefore, Notch activation may provide a potential route to
prevent premature depletion of satellite cells in DMD patients. Also, with the
respective of the long-term treatment of muscle dystrophy, our studies suggest
that the Notch inhibitor therapies may have potential side effects by accelerating
satellite cells exhaustion. However, continuous Notch activation fails to improve
regeneration of MDX muscles. I interpret this observation as the lack of myogenic
differentiation due to the inhibition of MyoD and myogenin by Notch signaling.
Taken together, a dynamic regulation of Notch signaling is necessary to balance
self-renewal and differentiation of satellite cells in order to ameliorate the longterm regenerative defects of dystrophic muscles.
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Figure 2.1 A Satellite Cells on Myofibers from WT and MDX Mice.
Single EDL muscle fibers were isolated from WT and MDX mice. Satellite cells
attached on the fibers were labeled with Pax7 (red). Nuclei were counterstained
with DAPI (blue). Central nuclei indicate MDX muscle regeneration.
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Figure 2.1 B Satellite Cell Number Declines with Age Rapidly in MDX mice.
Satellite cell numbers in single EDL muscle fibers were quantified from WT and
MDX mice at indicated ages. At each time point, n=3 mice with more than 20
fibers from each mouse were analyzed. Error bars represent s.e.
s.e.m.
m. * P<0.05.
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Figure 2.1 C Satellite Cell Number Increases More in MDX Mice after Injury.
Satellite cell numbers in single EDL muscle fibers were quantified from WT and
MDX mice at indicated ages after CTX treatment. At each ages, n=3 mice with
more than 20 fibers from each mouse were analyzed. Error bars represent
s.e.m.* P<0.05.
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Figure 2.1 D CTX-stimulated Relative Fold Change of Satellite Cell Number
Decreases with Age in MDX Mice.
Figure 2.1B showed the number of satellite cells without CTX injury while Figure
2.1C showed those numbers after CTX injury in WT and MDX mice at different
age points (1m, 2m, and 6m). The fold change calculated in Fig
Figure
ure 2.1D can be
indicative of the responsiveness of satellite cells to the acute muscle injury.
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Figure 2.1 E Satellite Cells Failed to Form Clusters in Culture of Single
Fibers from Aged MDX Mice.
Single fibers from 24 months old WT and MDX mice were cultured for 72hs.
Satellite cell clusters were formed in the single fiber culture. Satellite cell were
labeled with Pax7 (red) and MyoD (green). Nuclei were counterstained with DAPI
(blue).
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Figure 2.1 F The Number of Satellite Cells in One Cluster Was Reduced in
Culture of Single Fibers from Aged MDX Mice.
Single fibers from 12 and 24 months old WT and MDX mice were cultured for
72hs. Satellite cell numbers in one cluster were quantified. n=3 independent
experiment with more than 20 clusters analyzed in each experiment. Error bars
represent s.e.m. *P<0.05.
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Figure 2.2 A A Subset of Satellite Cells Are Self-renewing.
Single EDL muscle fibers were isolated from WT and MDX mice. Satellite cells
attached on the fibers were labeled with Pax7 (red) and β-gal (green). Pax7+βgal+ and Pax7+β-gal- Satellite Cells were indicated by asterisk and arrow
respectively. Nuclei were counterstained with DAPI (blue).

81

Figure 2.2 B The Abundance of Self-renewal Satellite Cells Is Normal in
Non-injured MDX Muscles.
Single EDL muscle fibers were isolated from WT and MDX mice without CTX
injury. Based on Pax7 and β-gal staining, percentages of self-renewal satellite
cells (Pax7+Myf5- (β-gal-)) were quantified at the indicated ages. n=3 mice with
more than 20 fibers analyzed in each mouse. Error bars represent s.e.m.
*P<0.05.
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Figure 2.2 C The Abundance of Self-renewal Satellite Cells Decreases in
MDX Muscles after Injury.
Single EDL muscle fibers were isolated from WT and MDX mice after CTX injury.
Based on Pax7 and β-gal staining, percentages of self-renewal satellite cells
(Pax7+Myf5- (β-gal-)) were quantified at the indicated ages. n=3 mice with more
than 20 fibers analyzed in each mouse. Error bar represents s.e.m. *P<0.05.
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Figure 2.2 D CTX-stimulated Relative Fold Change of Self-renewal Satellite
Cell Abundance Decreases in MDX Mice.
The CTX-stimulated relative fold change of self-renewal satellite cell abundance
was calculated from data in Figure 2.2B and Figure 2.2C. The fold changes
indicate the responsiveness of the self-renewal capability of satellite cells to the
acute muscle injury.
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Figure 2.2 E Different Subpopulations in Satellite Cell Clusters Are Going
through Self-renewal, Proliferation and Differentiation.
Single fibers from WT and MDX mice were cultured for 72hs. Satellite cell
clusters were formed in the single fiber culture. Satellite cell were labeled with
Pax7 (red) and MyoD (green). Quiescent, proliferating and differentiating cells
were labeled by Pax7+MyoD-, Pax7+MyoD+, and Pax7-MyoD staining,
respectively. Nuclei were counterstained with DAPI (blue).
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Figure 2.2 F Self-renewal Capacity Is Reduced in MDX Satellite Cells.
Single fibers from WT and MDX mice were cultured for 72hs. Percentages of
subpopulations of cells in one cluster were quantified based on Pax7 and MyoD
staining. n=3 independent experiment with more than 20 clusters analyzed in
each experiment. Error bars represent s.e.m. *P<0.05.
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Figure 2.2 G A Subset of Satellite Cells in One Cluster Tends to
Differentiate.
Single fibers from WT and MDX mice were cultured for 72hs. Satellite cell
clusters were formed in the single fiber culture. Satellite cell were labeled with
myogenin (red) and MyoD (green). Nuclei were counterstained with DAPI (blue).
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Figure 2.2 H MDX Satellite Cells Are More Prone to Terminal Differentiation.
Single fibers from WT and MDX mice were cultured for 72hs. Percentages of
myogenin+ cells per cluster were quantified based on myogenin and MyoD
staining. n=3 independent experiment with more than 20 clusters analyzed in
each experiment. Error bars represent s.e.m. *P<0.05.
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Figure 2.3 A The Notch Signaling Pathway Is Decreased in Young MDX
Muscles.
RNA were extracted from TA muscles collected from WT and MDX mice at 2
months age. n=6 mice for each group. Error bars represent s.e.m. *P<0.05.
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Figure 2.3 B The Notch Signaling Pathway Is Decreased in Aged MDX
Muscles
RNA were extracted from TA muscles collected from WT and MDX mice at 12
months age. n=6 mice for each group. Error bars represent s.e.m. *P<0.05.
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Figure 2.3 C The Cp-GFP Transgenic Mouse Is a Faithful Reporter of Notch
Signaling in Satellite Cells.
(a) GFP signal in a putative satellite cell on a freshly isolated live EDL myofiber.
(b) Double labeling with Pax7 (Red, satellite cell marker) and GFP (Green)
indicates that 83% satellite cells (Pax7+) are GFP- (b1), but 17% are GFP+ (b2,
n=102 cells counted from 3 mice). (c) Isolation of GFP+ and GFP- satellite cells
from the Cp-GFP mouse by fluorescent activated cell sorting using a7-integrin as
a positive selection marker. (d) Analysis of sorted a7-integrin+ cells indicates that
8% of cells are GFP+. (e) Realtime PCR analysis indicate that sorted GFP+
satellite cells expressed higher levels of Hes1, a canonical target of Notch
signaling. (f-h) Activation of Notch signaling turns on Cp-GFP in satellite cells in
vivo. Shown are images of Pax7 and GFP staining in control (f), Jag1
overexpressing (g), and RAMIC (NICD) overexpressing (h) TA muscle sections 7
days after electroporation of plasmids encoding empty vector, Jag1 cDNA and
NICD cDNA, respectively. Arrows point to Pax7+/GFP+ satellite cells. Figure 2.3
C was conducted by Dr. Yefei, Wen, Dr. Kazuki Kuroda, and Dr. Shihuan Kuang.
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Figure 2.3 C The Cp-GFP Transgenic Mouse Is a Faithful Reporter of Notch
Signaling in Satellite Cells.
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Figure 2.3 D The Notch Signaling Pathway Is Active in a Subset of Satellite
Cells.
Single EDL muscle fibers were isolated from Cp-GFP/MDX mice. Satellite cells
attached on the fibers were labeled with Pax7 (red) and GFP (green). The
asterisk and arrow represent Pax7+GFP+ and Pax7+GFP- satellite cells,
respectively. Nuclei were counterstained with DAPI (blue).
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Figure 2.3 E The Notch Activity Is Decreased in MDX Satellite Cells after
Injury.
Single EDL muscle fibers were isolated from WT and MDX mice without and with
CTX injury. Based on Pax7 and GFP staining, percentages of Notch active
satellite cells were quantified
quantified.. n=3 mice with more than 20 fibers analyzed in
each mouse. Error bars represent s.e.m. *P<0.05.
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Figure 2.3 F The Notch Signaling Pathway Is Impaired in MDX Myoblasts.
WT and MDX primary myoblast were cultured and collected for qPCR analysis
including Notch receptors (Notch 1, 2, and 3) and ligand (Jagged1) as well as
Notch target genes (Hey1 and Hey
HeyL).
L). 3 independent experiments were
performed. Error bars represent s.e.m. *P<0.05.
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Figure 2.4 A Different Subpopulations in Satellite Cell Clusters Are Going
through Self-renewal, Proliferation and Differentiation.
Muscle fibers from Rosa26NICD/MDX mice were cultured for 48h and infected by
Adenovirus (GFP and Cre) for 24 more hours. The cell clusters were labelled
with Pax7 (red) and MyoD (green). Quiescent, proliferating and differentiating
cells were labeled by Pax7+MyoD-, Pax7+MyoD+, and Pax7-MyoD staining,
respectively. Nuclei were counterstained with DAPI (blue).
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Figure 2.4 B Notch Activation Promotes Self-renewal of Satellite Cells.
Percentages of subpopulations of cells in one cluster were quantified based on
Pax7 and MyoD staining. n=3 independent experiment with more than 20
clusters analyzed in each experiment. Error bars represent s.e.m. *P<0.05.
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Figure 2.4 C Tamoxifen Activates the Notch Pathway in the Satellite Cells
of MDX/NICD+ Mice.
After tamoxifen injections, muscle fibers from MDX/NICD- (Pax7CreER/+/MDX) and
MDX/NICD+ (Pax7CreER/+/Rosa26NICD/MDX) mice were isolated and labeled with
Pax7 (red) and GFP (green). Nuclei were counterstained with DAPI (blue). GFP
signal is turned on by Cre in the Rosa26NICD-ires-nGFP mice (called Rosa26NICD
here).
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Figure 2.4 D Different Subpopulations of Satellite Cells Are Going through
Self-renewal, Proliferation and Differentiation.
Two-month-old MDX/NICD- and MDX/NICD+ mice were injected intraperitoneally
with Tamoxifen for 5 consecutive days. Then TA muscles were injected with CTX
and samples were collected 7 days after CTX injection. TA cross sections were
counterstained
tained with DAPI
stained with Pax7 (red) and MyoD (green). Nuclei were counters
(blue).
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Figure 2.4 E The Activation of Notch Increases Satellite Cell Number in
MDX Muscles.
After staining with Pax7, the number of satellite cells per field was quantified. n=3
mice with more than five fields were analyzed in each mouse. Error bars
represent s.e.m. *P<0.05.
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Figure 2.4 F The Activation of Notch in Satellite Cells Increases Selfrenewal in MDX Muscles.
After staining with Pax7 and MyoD, the ratios of self-renewal satellite cells
(Pax7+/MyoD-) per field were quantified. n=3 mice with more than five fields
were analyzed in each mouse. Error bars represent s.e.m. *P<0.05.
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Figure 2.4 G The Activation of Notch in Satellite Cells Deteriorates Muscle
Regeneration in MDX Mice.
Two-month-old MDX/NICD- and MDX/NICD+ mice were injected intraperitoneally
with Tamoxifen for 5 consecutive days. Then TA muscles were injected with CTX
and samples were collected 7 days after CTX injection. TA cross sections were
subjected to H&E staining.
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Figure 2.4 H The Activation of Notch in MDX Satellite Cells Leads to Less
Myofiber Formation in MDX Muscle.
The number of myofibers (>500 µm2) per field (1 mm2) was calculated. n=3 mice
with more than five fields were analyzed in each mouse. Error bars represent
s.e.m. *P<0.05.
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CHAPTER 3. CHARACTERIZATION OF THE ROLES OF BEX1 IN
MYOGENESIS

3.1

Abstract

Muscle regeneration is a complex but precisely orchestrated process
involving spatiotemporal regulation of genes critical for myogenesis. Brain
expressed x-linked gene 1 (Bex1) has recently been reported to be involved in
muscle regeneration. How Bex1 regulates myogenesis, however, is completely
unknown. To address this question, I first characterized the expression pattern of
Bex1 in muscle development and regeneration. Bex1 is expressed following
myogenic differentiation during embryonic muscle development. In adult muscle
regeneration, Bex1 is highly induced in the early stage of regeneration and
gradually disappears with muscle recovery. Consistently, in cultured myoblasts,
Bex1 was not expressed at the proliferation stage but highly expressed upon
induction of myogenic differentiation. Interestingly, Bex1 protein was mainly
localized to the nucleus of newly differentiated myotubes, suggesting a role of
Bex1 in regulating muscle gene expression. Using gain- and loss-of-function
studies in cultured myoblasts, I observed that overexpression of Bex1 did not
affect myogenic differentiation but dramatically promoted myoblast fusion.
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Conversely, Bex1 knockout myotubes exhibited fusion defects. These results
elucidate a novel role of Bex1 in myogenesis through regulating myoblast fusion.
Keywords: Bex1, muscle regeneration, myoblast fusion
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3.2

Introduction

Under normal conditions, mammalian adult skeletal muscle is relatively
stable with little nuclei turnover, no more than 1-2 percent per week
(Schmalbruch and Lewis, 2000). However, skeletal muscle is susceptible to a
variety of injuries. Upon injury, skeletal muscle has the outstanding capacity to
initiate a rapid and extensive repair process, known as muscle regeneration, to
prevent further muscle loss. Of note, muscle stem cells, satellite cells, play
indispensable roles in muscle regeneration (Sambasivan et al., 2011; von
Maltzahn et al., 2013). In the early stage of muscle regeneration, satellite cells
are activated from quiescence and proliferate as myoblasts to generate a
sufficient number of cells. Subsequently, a majority of the proliferating myoblasts
withdraw from the cell cycle and fuse to the injury sites to repair muscle damage.
The mechanism involved in muscle regeneration consists of multiple signaling
pathways. Unraveling the regulatory network behind muscle regeneration has
drawn intense research attention in the field.
Myoblast fusion is a crucial cellular process contributing to muscle
regeneration as well as muscle growth and development. Myoblast fusion is
characterized by cell attraction, migration, adhesion, and alignment followed by
the membrane rearrangement and finally resolution (Doberstein et al., 1997). The
fusion process occurs at two phases. The primary stage leads to the formation of
nascent myotubes with few nuclei from myoblast-myoblast fusion. The secondary
stage results in the formation of large syncytia with increased nuclear number
and augmented myotube size from myoblast fusion with nascent myotubes
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(Horsley and Pavlath, 2004). Many progresses have been made in unraveling
signaling pathways behind myoblast fusion in Drosophila, which occurs between
two genetically different cell subpopulations of founder and fusion-competent
myoblasts (Abmayr and Pavlath, 2012). Of note, ELMO-Myoblast city-Rac
pathway has been determined to play essential roles in myoblast fusion (Duan et
al., 2012; Geisbrecht et al., 2008; Rushton et al., 1995). Intriguingly, this
signaling pathway is well conserved between Drosophila and vertebrates. It has
been reported that ELMO-DOCK1 (ortholog of Myoblast city)-Rac also
coordinately control the myoblast fusion in mice (Laurin et al., 2008).
Furthermore, the ELMO-DOCK1-Rac pathway is under the control of brainspecific angiogenesis inhibitor (BAI) family members, including BAI1 and BAI3,
both of which have been corroborated to promote myoblast fusion (Hamoud et al.,
2014; Hochreiter-Hufford et al., 2013). Nevertheless, the signaling pathways
controlling myoblast fusion in vertebrates remains largely elusive.
The relevance of Brain Expressed X-linked gene 1 (Bex1) in muscle
regeneration was discovered in a microarray aimed to identify a panel of genes
with altered expression in cardiotoxin (CTX) induced muscle injury, a wellestablished model for muscle regeneration (Goetsch et al., 2003; Yan et al.,
2003). It was also supported by the observation that the expression level of Bex1
was dysregulated in MDX mice (Turk et al., 2005), which undergo progressive
muscle degeneration and regeneration. Bex1 knockout mice displayed altered
muscle regeneration, indicated by prolonged cell proliferation and delayed cell
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differentiation (Koo et al., 2007). However, the detailed mechanism of how Bex1
is involved in muscle regeneration has been lacking.
Bex1 belongs to a small growing family including six members with high
homology in gene sequences and structures but distinct in the expression pattern
and subcellular localization (Alvarez et al., 2005). Until now, the functions of
Bex1 have been largely unknown. Bex1 has been identified as a neuron
regeneration gene, as Bex1 knockout mice are deficient in axon regeneration
after sciatic-nerve injury(Khazaei et al., 2010). In addition, Bex1 levels are cellcycle dependent in PC12 neuron cells, with the lowest expression level in G1
phase and the highest level in S phase. Moreover, down-regulation of Bex1 is
necessary for neuron cells to exit the cell cycle, as overexpression of Bex1
results in sustained cell proliferation even under growth arrest conditions. Further
studies have confirmed that Bex1 regulates cell cycle by interacting with p75
neurotrophin receptor (p75NTR) to regulate the neurotrophin signaling pathway
(Vilar et al., 2006). Besides its roles in the nervous system, Bex1 has been
determined as a candidate tumor suppressor gene because its inactivation is
associated with the development of various types of tumors (Foltz et al., 2006;
Karakoula et al., 2014; Lee et al., 2013).
In this study, I observed that Bex1 is expressed after the induction of
myogenic differentiation and undergoes nuclear-cytoplasmic trafficking during
embryonic muscle development. I also characterized that Bex1 is temporally
induced during muscle regeneration. Consistently, I demonstrated that Bex1 is
exclusively expressed in differentiated myoblasts in vitro. By gain-of-function
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study, I determined that Bex1 promotes myoblast-myotube fusion without
affecting myogenic differentiation per se. Conversely, primary myoblasts from
Bex1 knockout mice are defective in fusion, although Bex1 knockout mice can
regenerate their injured muscles normally. These data suggested that Bex1 is
actively involved in the process of myogenesis by regulating myoblast fusion.
3.3

Materials and Methods
3.3.1 Animals

All procedures involving animal maintenance and experimental use were
performed based on the instructions established by Purdue University’s Animal
Care and Use Committee. Bex1 KO mice were provided by Prof. Frank L.
Margolis (Koo et al., 2007). Bex1 heterozygous mice were bred to generate Bex1
null and wild type littermates used as control in the experiments. The PCR
genotyping was done as previously described (Koo et al., 2007).
3.3.2 Muscle Injury and Regeneration
Muscle regeneration was induced by intramuscular injection of Cardiotoxin
(CTX; Sigma-Aldrich, St. Louis, MO). Mice were anesthetized with a ketaminexylazine cocktail, then 50μl of 10 mM CTX was injected into the Tibialis Anterior
(TA) muscle. Muscles were harvested at day 5 and 14 post injection for
histological studies. Age- and gender-matched control mice were used for each
experiment.
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3.3.3 Culture of skeletal muscle derived primary cells
Primary cells were isolated from limb skeletal muscles of 2-month old mice.
Muscles were minced and digested with a cocktail of type I collagenase and
dispase B mixture (Roche Applied Science) and subsequently cultured in growth
media (F-10 Ham’s medium supplemented with 20% fetal bovine serum, 4 ng/mL
basic fibroblast growth factor, and 1% penicillin-streptomycin) on collagen-coated
dishes. Upon confluence, cells were differentiated in myogenic differentiation
media (DMEM supplemented with 2% horse serum and 1% penicillinstreptomycin).
3.3.4 Cryosection
Fresh muscles were embedded in optimal cutting temperature (OCT)
compound (Sakura Finetek) and immediately frozen in dry ice-cooled isopentane.
Muscle blocks were cut by 10μm with a Leica CM 1850 cryostat instrument. The
sections were placed on Superfrost Plus glass slides (Electron Microscopy
Sciences).
3.3.5 Immunostaining and Image Capture
Muscle tissue sections and cell cultures were first fixed in 4% PFA solution
and blocked in the blocking buffer containing PBS, 5% goat serum, 2% bovine
serum albumin, 0.2% Triton X-100 and 0.1% sodium azide for 1 hour. Next, the
sections or cell cultures were incubated with primary antibodies diluted in
blocking buffer overnight at 4℃, then incubated with secondary antibodies and
4′,6-diamidino-2-phenylindole (DAPI) diluted in PBS for 30 minutes at room
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temperature, and finally mounted with Dako fluorescent mounting media
(Glostrup, Denmark). Fluorescent pictures were taken with a Coolsnap HQ CCD
camera (Photometrics, USA) driven by IP Lab software (Scanalytics, USA) in a
Leica DMI 6000B fluorescent microscope (Mannheim, Germany). As the analysis
of the immunofluorescence was qualitative, identical image handling and
fluorescence scoring criteria were applied in all the experiments.
3.3.6 Recombinant Adenovirus Construction and Infection
Recombinant adenoviruses expressing Bex1 were constructed using the
Adeasy system, including the adenoviral plasmid (pAdEasy-1) and the shuttle
vector (pAdTrack-CMV), both of which were kindly provided by Prof. Yongxu
Wang. The sequence of Bex1 was PCR amplified and cloned into the pAdTrackCMV vector. The recombination with the Adeasy1 plasmid and transfection to
HEK293 cells as well as amplification of the recombinant adenovirus were
performed as previously described (He et al., 1998). For infection experiments,
myoblasts were grown to 80% confluence and infected with virus for 48h at 37°C.
3.3.7 Quantitative Real-time Polymerase Chain Reaction
RNA was extracted and purified from muscles or cell cultures using Trizol,
followed by the digest with Turbo DNase (Ambion). Random hexamer primers
were used for the reverse transcription from RNA to cDNA. qPCR was performed
with a Light Cycler 480 machine (Roche). 18s was used as housekeeping gene
for normalization. For qPCR result analysis, 2-∆∆ct method was applied to
calculate the fold change.
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3.3.8 Protein Extraction and Western Blots Analysis
Total protein was extracted from muscles or cells using RIPA buffer
containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Nonidet P-40, 0.5%
sodium deoxycholate, and 0.1% sodium dodecyl sulfate (SDS). Protein
concentrations were measured by Pierce BCA protein assay reagent (Pierce
Biotechnology, Rockford, IL, USA). Proteins were separated by SDS–
polyacrylamide gel electrophoresis (SDS-PAGE), transferred to PVDF
membranes (Millipore Corp., Billerica, MA), and probed with specific antibodies
(Bex1, 1:5000 dilution, provided by Prof. Frank L. Margolis; Pax7, 1:10 culture
supernatant, DSHB, U Iowa; myogenin, 1:1000 dilution, Santa Cruz
Biotechnology; GAPDH, 1:1000 dilution, Santa Cruz Biotechnology), then
detected by chemiluminescence with FluorChem™ R System (ProteinSimple,
Santa Clara, CA, USA).
3.3.9 Statistical Analysis
Data are displayed with mean ± s.e.m. P-values were calculated by twotailed Student’s t-test. P-values <0.05 were considered to be statistically
significant.
3.4

Results

3.4.1 Bex1 Expression during Muscle Development and Regeneration
Previous studies demonstrated that Bex1 is predominantly expressed in
the central nervous system. Besides, it is widely expressed in various tissues
with high levels in the liver but less abundance in skeletal muscles (Alvarez et al.,
2005). However, it has been documented that Bex1 is highly expressed in
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somatic mesenchyme during muscle development (Vilar et al., 2006). Here I
sought to further characterize the in vivo expression pattern of Bex1 during
skeletal muscle development and regeneration.
In the mouse embryonic muscle development, Pax7 and myogenin have
been regarded as markers of muscle progenitor cells and differentiated myocytes,
respectively (Cheng et al., 1992; Relaix et al., 2006; Venuti et al., 1995). Using a
Bex1 antibody, I detected immunofluorescence in developing somites at
embryonic day (E) 10.5. Co-localization analysis indicates that Bex1 is absent in
the Pax7-expressing cells but co-localizes with a subpopulation of myogeninexpressing myogenic cells (Figure 3.1A), indicating that Bex1 is only expressed
in differentiating or differentiated muscle cells. Interestingly, analysis of
intracellular localization indicates that Bex1 is located in the cytoplasm at E10.5
but in the nucleus at E12.5 (Figure 3.1B). The late expression of Bex1 in
myogenin-expressing cells suggests that Bex1 might play a role in myogenic
differentiation.
I also examined the expression pattern of Bex1 in postnatal muscle
regeneration. Before muscle injury, Bex1 was barely detectable in rested
muscles (Figure 3.1C), suggesting that Bex1 is not required for maintaining
normal muscle function. During muscle regeneration, Bex1 was highly induced in
the cytoplasm of regenerating muscles at Day 5 but its expression disappeared
at Day 14 (Figure 3.1C), indicative of a spatiotemporal expression pattern. In
agreement with this observation, Bex1 transcript level was detected to peak at
Day 5 post CTX injury (Figure 3.1D), when myoblasts have been extensively
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expanded and are fusion competent (Robertson et al., 1990). Then Bex1
expression gradually disappeared afterwards until nearly undetectable at Day 14
(Figure 3.1D), when the muscle regeneration is largely completed. Altogether,
these data indicate that Bex1 is actively involved in embryonic and postnatal
myogenesis.
3.4.2 Bex1 is Exclusively Expressed in Differentiated Myoblasts in vitro.
In order to better understand the role of Bex1 in the myogenesis, I also
examined the expression pattern of Bex1 in cultured primary myoblasts. In
agreement with the expression pattern of Bex1 in embryonic muscle
development, Bex1 is absent in proliferating myoblasts while its expression is
highly induced by differentiation (Figure 3.2A). Consistently, the expression
levels of Bex1 mRNA and protein were increased in differentiated myocytes
compared to undifferentiated myblasts (Figure 3.2B and 2C). In addition, Bex1
expression is limited to the nuclei of differentiated myotubes (Figure 3.2A).
Moreover, single fiber culture experiment was performed to investigate the Bex1
expression pattern in myoblasts attached to the host fiber. After culture for 72
hours, Bex1 is not expressed in Pax7+ (Figure 3.2D) or KI67+ cells (Figure
3.2E), supporting the notion that Bex1 is not expressed until differentiation. While
the expression of Bex1 emerged in the myogenin+ cells, mainly in the nucleus
but also in the cytoplasm (Figure 3.2F), confirming that Bex1 is induced upon
myogenic differentiation. Notably, given the lack of Bex1 localization in the
nucleus of mature myotubes, these data suggest that Bex1 undergoes a nucleus
to cytoplasm transition during maturation of nascent myotubes. Moreover, the
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exclusive expression pattern of Bex1 in nascent myotubes prompted us to
explore the roles of Bex1 in myogenic differentiation.
3.4.3 Bex1 does not Regulate Cell Cycle Withdrawal in Myogenic Cells.
Prior studies demonstrated that overexpression of Bex1 in neuron cells
renders resistance to NGF- or serum withdrawal-induced growth arrest, whereas
Bex1 knockdown led to cell cycle exit and premature differentiation. Furthermore,
Bex1 was determined to interact with p75NTR to regulate cell cycle withdrawal
(Vilar et al., 2006). Given that Bex1 is cell-cycle-regulated with the lowest in G1
phase and highest in S phase in neuron cells, I first examined whether Bex1
could be accumulated in the specific phase of cell cycle. However, I observed
that Bex1 was undetectable with treatment of mimosine, thymidine, and
nocodazole (arresting cells in the G1, S, G2/M phase, respectively) (Figure
3.3A), which suggests that Bex1 is not dependent on cell cycle progression.
Moreover, I performed FACS analysis on undifferentiated myoblast infected by
adenovirus expressing GFP and Bex1. The ectopic expression of Bex1 in
proliferating myoblasts failed to promote cell cycle withdrawal, indicated by the
comparable distribution of cells in G1, S, G2/M phase (Figure 3.3B).
Quantification of different cell groups confirmed that Bex1 overexpression did not
affect the percentages of myoblast population in G1, S and G2/M phases.
Collectively, these data demonstrated that Bex1 is not involved in myoblast cell
cycle regulation.
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3.4.4 Bex1 Promotes Myoblast-Myotube Fusion in vitro.
I further investigated the mechanism of how Bex1 regulates myogenic
differentiation. It was reported that Bex1 can directly interact with Calmodulin
(CaM), the ubiquitous Ca2+ -binding protein, in a Ca2+-dependent manner in vitro
(Koo et al., 2007). CaM can activate multiple CaM-dependent enzymes, such as
Calcineurin, to mediate the regulatory effect of Ca2+ signaling pathway, which
plays indispensable roles in the fusion of myoblast into multinucleated myotubes
(Bar-Sagi and Prives, 1983; Bijlenga et al., 2000; Constantin et al., 1996; Shin et
al., 1996).
To test whether Bex1 is involved in the myoblast fusion, I performed gainof-function study on primary myoblasts. Bex1 mRNA transcript and protein were
significantly increased after infection (Figure 3.4A and 3.4G). After differentiation
for 24hs, both GFP control and Bex1 overexpressed myoblasts started to form
nascent myotubes with few nuclei and are indistinguishable in myofiber size
(Figure 3.4B), confirmed by comparable differentiation index and fusion index
(Figure 3.4C and 3.4D). This suggested that Bex1 did not regulate the initial
formation of myotubes. Interestingly, after differentiation for 96hs, Bex1
overexpression caused a dramatic accumulation of nuclei in mature myotubes
(Figure 3.4E). The percentages of myofibers with more than 5 nuclei was
markedly increased by Bex1 overexpression (13.56% vs 26.70%) (Figure 3.4F),
suggesting that Bex1 positively regulates myoblast fusion with myotubes.
However, the expression of myogenic differentiation markers, myogenin and
myosin heavy chain (MHC), were comparable between two groups (Figure 3.4G),
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indicating that Bex1 functions specifically through promoting myoblast fusion
rather than regulating myogenic differentiation per se. Meanwhile, I also
electroporated plasmid encoding Bex1 to C2C12 myoblasts to investigate the
roles of Bex1 in myoblast fusion (Figure 3.4H). Consistently, the average
number of myonuclei inside Bex1 overexpressed myotubes increased
dramatically (4.7 vs 9.4) (Figure 3.4I), supporting the notion that Bex1 could
promote myoblast fusion. Altogether, these data suggest that Bex1 promotes
myoblast fusion without affecting myogenic differentiation.
3.4.5 Bex1 Knockout Myoblasts are Defective in Myoblast-myotube Fusion in
vitro.
To confirm definitively that Bex1 promotes myoblast fusion, I bred Bex1
heterozygous mice to obtain the knockout mice. I administrated CTX to injure TA
muscles and allowed muscle regeneration for 14 days. The Bex1 knockout
muscles did not exhibit obvious regeneration defects at day 5 and day 14.
Through laminin staining, I quantified the size of regenerated myofibers, a direct
indicator of myoblast fusion. Bex1 knockout mice did not exhibit obvious fusion
defects (Figure 3.5A), indicated by a cohort of indistinguishable fiber diameter
classes (Figure 3.5B).
By culturing primary myoblast from Bex1 knockout mice, I performed a lossof-function study to investigate the effects of loss of Bex1 on myoblast fusion in
vitro. The primary myoblasts from Bex1 knockout mice were normal in terms of
proliferation capacity like WT myoblasts, indicated by normal growth curve and
comparable levels of Ki67, the well-established marker for cell proliferation (data
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not shown). After differentiation for 24hs, Bex1 knockout myoblasts formed
nascent myotubes normally, which is comparable with WT control in terms of
nuclei number in the myotubes and fiber size (data not shown). However, after
differentiation for 96hs, WT control myoblasts formed large myofibers with
multiple nuclei inside whereas Bex1 knockout myoblasts failed to enlarge fiber
size and accumulate myonuclei efficiently (Figure 3.5C). The percentages of
myofibers with more than 5 nuclei was significantly reduced (43.43% vs 24.45%)
(Figure 3.5D), suggesting that Bex1 knockout led to significant defects of
myoblast fusion with myotubes. Besides, in accordance with the notion that Bex1
overexpression did not affect myoblast differentiation, knocking-out Bex1 did not
impair the myoblast differentiation per se, indicated by the comparable
expression levels of myogenic differentiation markers, myogenin and MHC
(Figure 3.5E). Altogether, these data provided compelling evidence that Bex1
promotes myoblast-myotube fusion.
3.5

Discussions

In this study, I identified that Bex1 is expressed following myogenic
differentiation during embryonic muscle development as well as temporarily
induced during muscle regeneration. I also determined that Bex1 is specifically
expressed in differentiated myocytes in vitro. Of note, Bex1 undergoes
translocation from the cytoplasm to the nucleus as differentiation proceeds. I
verified that Bex1 can promote myoblast-myotube fusion without affecting
differentiation progression. Conversely, I demonstrated that Bex1 knockout
caused impaired myoblast-myotube fusion. These results collectively elucidate
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the role of Bex1 in myogenesis that Bex1 could promote myoblast-myotube
fusion.
It has been well documented that Bex1 is abundantly expressed in neurons
with a dynamic nucleocytoplasmic distribution pattern. This nucleocytoplasmic
trafficking was associated with neuron growth factor (NGF) induced p75NTR
signaling pathway (Lee et al., 2013). Here, I also observed the nucleocytoplasmic
distribution pattern in myogenic cells. Bex1 was initially diffused in the cytoplasm
but translocated to the nucleus in the late stage of differentiation. This
nucleocytoplasmic trafficking could also be related to the p75NTR signaling
pathway as p75NTR has been reported to have high expression levels in
developing rat myoblasts as well as in rat and chicken muscles (Ernfors et al.,
1988; Lomen-Hoerth and Shooter, 1995; Raivich et al., 1985; Raivich et al., 1987;
Schecterson and Bothwell, 1992; Yamamoto et al., 1996). Another possible
signaling pathway is the Ca2+ dependent signaling pathway, which plays
indispensable roles in myogenic differentiation. It has been reported that Bex1
can directly interact with Calmodulin (CaM) (Koo et al., 2007), the ubiquitous
Ca2+ -binding protein, which mediates the uptake of various nuclear proteins
(Sweitzer and Hanover, 1996), such as NFAT isoforms. Future work can be
focused on investigating which signaling pathway controls the nucleocytoplasmic
trafficking of Bex1 in myogenesis.
Mammalian skeletal muscles are generated through the proliferation,
differentiation and fusion of myoblasts into multinucleated myofibers. The
spatiotemporal expression pattern of Bex1 suggests that Bex1 might be involved
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in critical steps during myogenic differentiation. Previous studies demonstrated
that Bex1 knockout mice posed prolonged proliferation and delayed
differentiation kinetics compared to WT mice during muscle regeneration (Koo et
al., 2007), indicating the defects of cell cycle withdrawal due to the loss of Bex1.
However, our studies show that the myoblasts cultured from Bex1 knockout mice
were not defective in proliferation in vitro. Also, Bex1 ectopic expression did not
regulate cell cycle withdrawal and further myogenic differentiation per se. The
observation of prolonged proliferation and delayed differentiation might be due to
other cell types in that muscle regeneration involves proliferation of various types
of cells, such as immune cells.
Furthermore, I verified that Bex1 could positively regulate myoblast fusion.
Interestingly, the myoblast-myoblast fusion was not affected by either Bex1
overexpression or knock-out. However, the ectopic expression of Bex1
dramatically increased the myoblast-myotube fusion in vitro while Bex1 knockout
myoblasts were defective in the process. Recently, it was reported that apoptotic
cells can induce ELMO/DOCK1/Rac pathway through the cell surface protein
BAI1 to enhance myoblast fusion (Hochreiter-Hufford et al., 2013). Besides,
Bex3 has been identified to interact with p75NTR to mediate apoptosis pathway
(Mukai et al., 2000). Given that Bex1 and Bex3 share the similar sequences
implicated in p75NTR binding (Vilar et al., 2006), it is plausible to hypothesize
that Bex1 could promote apoptosis during myogenic differentiation, which
initiates the ELMO/DOCK1/Rac signaling pathway and mediates the fusion.
However, during the muscle regeneration, Bex1 knockout mice did not exhibit
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deficient myoblast fusion as well as impaired muscle regeneration. This might be
attributable to the compensation effect of other Bex family members due to the
loss of Bex1. Or, the massive degeneration overwhelmed the effect of loss of
Bex1 on cell apoptosis, which further masked the defects of myoblast fusion.
Generating Bex1 transgenic mice may provide additional clues to study the roles
of Bex1 in muscle regeneration. Nevertheless, this study contributes to our
understanding the cellular and molecular mechanism of myogenesis, especially
the myoblast fusion. These data may have implication in the development of
therapeutic strategies of muscle diseases.
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Figure 3.1 A Bex1 Is Expressed During Myogenic Differentiation in vivo.
Embryos at E10.5 stage were sectioned and applied in the immunostaining with
antibodies recognizing Bex1 (green) together with Pax7 (red, left panel) and
myogenin (red, right panel), showing a concurrent expression pattern of Bex1
and myogenin. Nuclei were counterstained with DAPI (blue).
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Figure 3.1 B Bex1 Translocates from Cytoplasm to Nucleus with Myoblast
Differentiation in vivo.
Embryos at E10.5 (left panels) and E12.5 stage (right panels) were sectioned
and applied in the immunostaining with antibodies recognizing myogenin (red)
and Bex1 (green). Bex1 undergoes cytonucleotrafficking from cytoplasm at E10.5
to nucleus at E12.5. Nuclei were counterstained with DAPI (blue).
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Figure 3.1 C Bex1 Is Temporarily Expressed during Muscle Regeneration.
TA muscles were injected with CTX and samples were collected at indicated
points after CTX injection. TA cross se
sections
ctions were stained with Bex1 (red). Nuclei
were counterstained with DAPI (cyan).
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Figure 3.1 D Bex1 Is Highly Induced at Day 5 post Injury but Gradually
Disappears afterwards.
TA muscles were injected with CTX and sam
samples
ples were collected at indicated
points after CTX injection. RNA were extracted from muscles and compared
between rested and injured muscles at different time points. The dot line
indicates the expression level of Bex1 in rested muscles. N=3. Error bars
represent s.e.m. *P<0.05 compared with rested muscles.
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Figure 3.2 A Bex1 Is Exclusively Expressed in Differentiated Myocytes.
Primary myoblasts were cultured and induced for different
differentiation.
iation. Cell culture at
different days post differentiation induction was applied in the immunostaining
with antibody recognizing Bex1 (red). Nuclei were counterstained with DAPI
(cyan).
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Figure 3.2 B The Expression Level of Bex1 Tanscript Is Increased with
Differentiation.
Primary myoblasts were cultured and induced for different
differentiation.
iation. RNAs were
extracted from cell culture at different days post differentiation induction. N=3
independent experiments. Error bars represent s.e.m. *P<0.05.
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Figure 3.2 C The Expression Level of Bex1 Protein Is Increased with
Differentiation.
Primary myoblasts were cultured and induced for different
differentiation.
iation. Proteins were
extracted from cell culture at different days post differentiation induction. N=3
independent experiments.
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Figure 3.2 D Bex1 Is Not Expressed in Undifferentiated Myoblasts.
Single fibers were isolated and cultured for 72hs. Satellite cell clusters were
formed and labeled with Bex1 (green) together with Pax7 (red, top). Nuclei were
counterstained with DAPI (blue).
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Figure 3.2 E Bex1 Is Not Expressed in Proliferating Myoblasts.
Single fibers were isolated and cultured for 72hs. Satellite cell clusters were
formed and labeled with Bex1 (green) together with Ki67 (red, top). Nuclei were
counterstained with DAPI (blue).
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Figure 3.2 F Bex1 Is Expressed in Differentiated Myoblast.
Single fibers were isolated and cultured for 72hs. Satellite cell clusters were
formed and labeled with Bex1 (green) together with myogenin (red, top). Nuclei
were counterstained with DAPI (blue).
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Figure 3.3 A Bex1 Is Not Cell-cycle-regulated.
Primary myoblasts were cultured and treated with mimosine, thymidine, and
nocodazole, which can arrest cells at G1, S, and G2/M phases, respectively. UD,
undifferentiated myoblast. D, differentiated myotubes. Proteins were collected
and subjected to SDS page. N=3 independent experiments.
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Figure 3.3 B The Ectopic Expression of Bex1 Does Not Promote Cell Cycle
Withdrawal.
Primary myoblasts were infected with virus expressing GFP and Bex1 for 48hs.
Cell population at different phases of cell cycle were separated by FACS.
Quantification of ratio of cell population at G1, S, and G2/M phases. N=3
independent experiments.
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Figure 3.4 A The Expression Level of Bex1 Transcript Was Increased after
Infection of Adeno-virus Expressing Bex1.
Primary myoblasts were cultured and infected with virus expressing GFP and
Bex1 for 48hs. RNAs were extracted and compared between GFP and Bex1
groups. N=3 independent experiments. Error bars represent s.e.m. *P<0.05.
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Figure 3.4 B The Bex1 Over-expression Does Not Affect Myoblastmyoblast Fusion.
Primary myoblasts were cultured and differentiated with viruses expressing GFP
differentiation,, cells were immunostained
and Bex1 upon confluence. After 24hs differentiation
with antibody recognizing MHC (red). Nuclei were counterstained with DAPI
(cyan).
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Figure 3.4 C The Bex1 Over-expression in Myoblast Does Not Affect Early
Differentiation
Primary myoblasts were cultured and differentiated with viruses expressing GFP
differentiation,, differentiation index was
and Bex1 upon confluence. After 24hs differentiation
calculated as the ratio of nuclei in Myosin+ cells. n=3 independent experiments.
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Figure 3.4 D The Bex1 Over-expression in Myoblasts Does Not Affect
Primary Fusion.
Primary myoblasts were cultured and differentiated with viruses expressing GFP
differentiation,, fusion index was calculated
and Bex1 upon confluence. After 24hs differentiation
as the ratio of nuclei in Myosin+ myotubes. n=3.
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Figure 3.4 E The Bex1 Over-expression Promotes Myoblast-myotube
Fusion.
Primary myoblasts were cultured and differentiated upon confluence. After 24hs
differentiation, adeno-virus expressing GFP and Bex1 was added with 96 more
hours differentiation and then immunostained with the antibody recognizing MHC
(red). Nuclei were counterstained with DAPI (cyan).
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Figure 3.4 F The Bex1 Over-expression Increases Myoblast-myotube
Fusion.
Primary myoblasts were cultured and differentiated with infection of virus
expressing GFP and Bex1. Percentages of myosin+ cells with different nuclei
number in each field were calculated. ≥ 200 cells were analyzed with 5
independent experiments. Error bars represent s.e.m. *P<0.05 compared with
GFP-infected cells.
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Figure 3.4 G The Bex1 Over-expression Does Not Affect Myoblast
Differentiation per se.
Primary myoblasts were cultured and differentiated with infection of virus
expressing GFP and Bex1. Proteins were extracted after differentiation and
subjected to western blot analysis. GAPDH worked as a control. N=3
independent experiments.
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Figure 3.4 H The Bex1 Over-expression Promotes Fusion in C2C12
Myoblasts.
C2C12 myoblasts were electroporated with plasmids expressing GFP and GFPBex1 then induced for differentiation for 6 days. Myotubes were immunostained
with the antibody recognizing MHC (red). Nuclei were counterstained with DAPI
(blue).

141

Figure 3.4 I The Bex1 Over-expression Increases the Number of Nuclei in
C2C12 Myotubes.
After immunostaining with the MHC antibody, tthe
he numbers of nuclei in GFP+ and
GFP-Bex1+ myotubes were calculated. N=3 independent experiments. Error
bars represent s.e.m. *P<0.05 compared with GFP plasmid transfected cells.
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Figure 3.5 A The Myofiber Size in Bex1 Knockout Mice Appears Normal
after Regeneration.
Knockout
out mice were injected with CTX. After 14
TA muscles from WT and Bex1 Knock
days regeneration, TA muscles were sectioned and stained with antibody against
laminin (green). N=3 mice.

143

Figure 3.5 B Bex1 Knockout Mice Do Not Exhibit Smaller Myofibers after
Regeneration.
After CTX-induced muscle regeneration for 14 days, TA muscles were sectioned
and stained with antibody against laminin (green). The fiber sizes were
calculated by ImageJ plus software. N=3.
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Figure 3.5 C Primay Myoblasts of Bex1 Knockout Mice Are Defective in
Myoblast-myotube Fusion.
Primary myoblasts were cultured from WT and Bex1 knockout mice and
differentiated for 72hs upon confluence. Myotubes were Immunostained with the
antibody recognizing MHC (red). Nuclei were counterstained with DAPI (cyan).
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Myoblast--myotube
Figure 3.5 D Bex1 Knockout Leads to the Defective Myoblast
Fusion.
Primary myoblast from WT and Bex1 knockout mice were cultured and
differentiated for 72hs upon conflunce. Percentages of myosin+ cells with
different nuclei number in each field were calculated. ≥ 200 cells were analyzed
with 3 independent experiments. Error bars represent s.e.m. *P<0.05 compared
with WT cells.
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Figure 3.5 E Bex1 Knockout Does Not Affect Myogenic Differentiation per
se.
Primary myoblasts were cultured from WT and Bex1 Knockout mice, then
differentiated upon confluence. Proteins were extracted after differentiation and
subjected to western blot analysis. GAPDH worked as a control. N=3
independent experiments.
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CHAPTER 4. IMPLICATION AND FUTURE DIRECTIONS

4.1

Implication

Muscle regeneration is a highly orchestrated process involving multiple
types of cells, including satellite cells and a poorly determined collection of cell
populations. In response to environmental cues, those cells could adapt and
cooperate with each other to maintain or recover homeostasis in skeletal
muscles, wherein a spectrum of signaling pathways and transcriptional factors
have been determined to regulate cellular behaviors. Of note, satellite cells play
pivotal roles in contributing to muscle regeneration and satellite cell activation,
proliferation and differentiation are precisely controlled by a cellular and
molecular regulatory network. However, under some pathophysiological or aging
conditions, the delicate balance of the cellular and molecular regulatory network
could be perturbed so that muscle wasting may ensue, which is extremely
detrimental to health and may even lead to death. The studies in this dissertation
aim to explore the cellular and molecular mechanism of muscle regeneration in
MDX mouse, a well-characterized model for Duchenne muscular dystrophy, as
well as Bex1 knockout mouse, a newly-studied model for investigating the novel
roles of Bex1 in skeletal muscles. The findings from this dissertation will not only
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facilitate understanding the cellular and molecular regulatory network in muscle
development and regeneration but also shed light on providing therapeutic
avenues for the prevention and treatment of muscle diseases.
4.2

Future Directions

In this dissertation, Notch signaling pathway and Bex1 were identified with
altered expression levels during muscle regeneration. This is supported by the
fact that both the Notch signaling pathway and Bex1 were up-regulated in
dystrophic muscles (Turk et al., 2005). Furthermore, this dissertation introduced
the Notch signaling pathway and Bex1 into the regulatory network during specific
phases of myogenesis. In detail, Chapter 2 presented that the Notch signaling
pathway promoted self-renewal capacity of satellite cells and inhibited myogenic
differentiation whereas Chapter 3 elaborated that Bex1 boosts myoblast fusion
with myotubes during myogenic differentiation. Besides, this dissertation did not
exclude the possibility that the Notch signaling pathway and Bex1 also play
important roles in other periods of myogenesis. Indeed, more intriguing
hypotheses pertaining to the Notch signaling pathway and Bex1 in muscle
remain unsolved and are worthwhile for future endeavors. This chapter covers
some relevant hypotheses based on the aforementioned studies.
4.2.1 Notch in Skeletal Muscles
Notch signaling pathway is evolutionarily conserved and has been
previously implicated in cell proliferation and differentiation as well as cell fate
determination (Artavanis-Tsakonas et al., 1999). In the myogenesis, it was
reported that Notch is involved in multiple signature events from satellite cells to
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myoblasts then to myotubes (Conboy and Rando, 2002; Kitzmann et al., 2006).
In the satellite cells, Notch is highly active in promoting self-renewal capability
through direct regulating Pax7 and inhibiting premature myogenic differentiation
partially by targeting MyoD (Wen et al., 2012). Conversely, the mouse with Notch
blockage in satellite cells displays dystrophic muscle phenotypes and spoiled
muscle regeneration (Lin et al., 2013).
Consistently, Chapter 2 in this dissertation proved that Notch signaling
pathway in MDX was disturbed, which led to the self-renewal defects and
progressive depletion of satellite cell pool. Constitutive activation of Notch
rescued the self-renewal defect but deteriorated muscle regeneration, which was
largely attributable to the lasting inhibition of myogenic differentiation (Wen et al.,
2012). Nevertheless, this study pointed to a crucial role of Notch in maintaining
the pool size of satellite cells for long-term treatment of DMD.
Furthermore, given that muscle regeneration could be improved by the
temporarily activation of Notch through the antibody against Notch 1 receptor
(Conboy et al., 2003), we interpret that Notch activation within a short time period
may be a promising direction when Notch is manipulated to treat muscular
dystrophy. To do that, the proteins of Notch ligands can be synthesized. And, the
pharmacological activators of Notch can be developed. These reagents will
activate Notch temporarily, and facilitate satellite cell self-renewal without
progressively blocking myogenic differentiation. Besides, one potential
application is to apply these Notch temporal activators to satellite cell

150
transplantation, which might increase the cell survival rate and contribute muscle
regeneration more efficiently.
Another interesting future endeavor can be made to search for new target
to balance the self-renewal and myogenic differentiation of satellite cells. As the
Wnt signaling pathway is also highly active in muscle regeneration and plays
roles in antagonizing the Notch pathway to initiate terminal differentiation. Notch
pathway activation combined with Wnt pathway manipulation may be conducive
to improve muscle pathology of MDX in terms of not only rescuing self-renewal
but also promoting myogenic differentiation. This could be feasible thanks to the
bridging roles of GSK3-β between Notch and Wnt pathways as GSK3-β can not
only interact with NICD to regulate Notch target genes but also plays pivotal roles
in stabilizing β-catenin to activate Wnt signaling pathway (Espinosa et al., 2003;
Foltz et al., 2002). Therefore, manipulation of GSK3-β in myogenic lineage cells
in a spatiotemporal manner could be promising in the treatment of dystrophic
muscle in the both long term and short term runs.
4.2.2 Bex1 in Skeletal Muscles
As a novel gene studied in muscle development and regeneration, Bex1
has a relatively specific functional pattern as the expression of Bex1 is limited to
the stage of myogenic differentiation, which is evidenced by the observation of
both in vivo and in vitro in Chapter 3. Chapter 3 also reported that Bex1 has no
dramatic regulatory effects on the expression of myogenic differentiation markers,
such as myogenin and MHC. Interestingly, Bex1 could positively regulate
myoblast fusion with growing myotubes. Myoblast fusion plays fundamental roles
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in both muscle development and muscle regeneration. The fusion process
requires a series of cellular events including migration, alignment, adhesion and
membrane fusion. It is still completely unknown in which specific stages of fusion
Bex1 is involved.
Currently, although various signaling pathways and transcriptional factors
have been identified to regulate the fusion process, the cellular and molecular
mechanism of myoblast fusion is still largely unknown. A good study model of
myoblast fusion is Drosophila, wherein researchers have characterized two
parallel signaling pathways of Mbc (myoblast city)/Rac and Loner/Rac (Chen et
al., 2003; Hakeda-Suzuki et al., 2002; Rushton et al., 1995). Due to the
conservation of muscle fusion regulation through species, those two pathways
also have significant relevance to study myoblast fusion in mammals. As such, it
will be of interest to target the interaction of Bex1 with potential players in these
two pathways.
The current cellular and molecular knowledge of Bex1 has elicited us to
hypothesize that Bex1 could regulate myoblast fusion through these wellestablished signaling pathways. For instance, the interaction of Bex1 and
calmodulin suggested that Bex1 may be implicated in the calcium signaling
pathway (Koo et al., 2007), which has been corroborated to regulate fusion
through various targets, including NFATc2 isoform and N-cadherin (Horsley et al.,
2003; Mege et al., 1992). Of note, the calcium-dependent N-cadherin could
interact with Loner to mediate the fusion process (Dottermusch-Heidel et al.,
2012), indicating a possible mechanism of Bex1 function. Thus, an in-depth
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investigation of how Bex1 regulates myoblast fusion should be attempted
according to the biochemistry and cellular biology knowledge associated with
Bex1.
Besides the roles of Bex1 in the fusion characterized in this dissertation,
there might be other intriguing hypotheses about Bex1 in the muscle
regeneration. For example, Bex1 is abundantly expressed in neurons, which are
closely related to muscle development and regeneration. The motor neuron and
its innervated muscle fibers comprise the motor unit. The motor neurons play key
roles in the muscle function as well as muscle growth, especially the distribution
of muscle fiber types (Burke et al., 1971; Calabria et al., 2009; Sohal and Holt,
1980). As Bex1 knockout mice displayed a compromised endurance in the
Treadmill-running tolerance test (24% lower than WT) (Koo et al., 2007), it is
plausible to hypothesize that the absence of Bex1 might lead to deficient motor
neurons, which consequently impairs the muscle performance. These studies
might have great implications in searching for therapeutic targets for the
treatment of neuromuscular diseases as well as other metabolic diseases.
4.3

Conclusion

This dissertation focused on the roles of the Notch signaling pathway and
Bex1 in the muscle regeneration. In this chapter, more intriguing hypotheses
have been covered in this chapter and requires further studies to verify. With the
increasingly understanding of muscle biology and more advanced technologies in
the future, those hypotheses will be tested more precisely and efficiently. Those
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results will definitely enrich our scope of knowledge about the cellular and
molecular mechanism of muscle development and regeneration.
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